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Abstract 
According to the CDC the prevalence of Autism Spectrum Disorder (ASD) in 
males compared to females is approximately 5:1. Skuse et al. hypothesized that 
imprinted genes on the X chromosome could account for this sex bias. Genomic 
imprinting is defined as differential gene expression dependent upon the parental origin 
of the allele. While genomic imprinting on autosomes has been well classified, no 
imprinting mechanism on the sex chromosomes has been discovered. This work 
presents an investigation into the regulation of expression governing the imprinted locus 
of X-Linked Lymphocyte Regulated 3b/4b/4c (Xlr3/4), and closely linked ASD candidate 
gene, Transketolase-Like 1 (TKTL1), in the developing central nervous system of the 
laboratory mouse. Examination of epigenetic signatures and the chromatin environment 
including differential DNA methylation, differential nucleosome positioning, H3.3 
deposition and G-quadruplex formation, suggests that epimutations in these loci may 
underlie disease association. 
Transketolases play a pivotal role in the Pentose Phosphate Pathway (PPP), and 
dysfunction in the non-oxidative phase of the PPP has been linked to 
neurodegenerative disorders and cancers. This work explores the expression of TKTL1 
in human brain sub-regions of ASD patients compared to neurotypical individuals as 
well as the functional role TKTL1 plays in the PPP. It is observed that TKTL1 may not 
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function as a transketolase in the pathway, but may play a critical regulatory role as a 
competitive inhibitor. 
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Chapter 1: Introduction 
 
Overview 
 
The CDC reports there is approximately a 5:1 ratio in the occurrence of Autism 
Spectrum Disorder (ASD) in males compared to females, but the reason for this male 
bias is currently unknown1. Dr. David Skuse’s X-linked imprinting theory proposes that 
this bias is due to the presence of an imprinted gene(s) on the X chromosome2. In 
mammals, imprinted genes are distinguished by the fact that they exhibit parent-specific 
gene expression (PSGE). Currently, approximately 200 imprinted genes have been 
identified in mammals3, however only six genes showing PSGE have been identified on 
the mouse X chromosome and none have been reported for the human X 
chromosome4. 
In 1997 Skuse et al. theorized that the presence of imprinted genes on the X 
chromosome may explain a parent-of-origin associated social cognitive deficiency seen 
in patients with Turner Syndrome (TS), i.e. X chromosome monosomy. Skuse et al. 
observed decreased social cognitive ability in TS females who inherited the maternal X 
chromosome (45XM) compared to 45,XP TS females2. From this work a research path 
emerged to investigate X-linked imprinted genes that may play a role in social cognitive 
function and neurodevelopment. At the time only a few dozen imprinted genes were 
known and all were autosomally linked. 
In 2005, Raefski and O’Neill reported the discovery of the first X-linked imprinted 
cluster of genes including Xlr3b, Xlr4b, and Xlr4c on the mouse X chromosome (which 
will hence be referred to as the Xlr3/4 locus)5. While imprinting at autosomal loci was 
known to be regulated by parent-specific methylation at critical Differentially Methylated 
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Regions (DMRs), no DMR has been identified at this Xlr3/4 locus, suggesting a novel 
imprinting mechanism exists to maintain the imprinting status of these genes. Evidence 
to date suggests the chromatin environment could play a role in the PSGE mechanism 
seen at the Xlr3b/4 locus. 
In addition to DMRs autosomal imprinted genes can be distinguished by the 
presence of other allele-specific epigenetic marks. The regulation and maintenance of 
PSGE at autosomal imprinted loci is accomplished, in general, by well-characterized 
mechanisms utilizing DMR’s and specific histone modifications6. Imprinting mechanisms 
for many autosomally imprinted genes have been well studied and are well understood. 
However, an imprinting mechanism for sex chromosome linked genes has yet to be 
identified and characterized. 
This work explores the hypothesis that Xlr3b, Xlr4b, and Xlr4c are imprinted by a 
previously unidentified mechanism that does not involve the classic epigenetic marks 
known to exist at autosomal imprinted loci. Additionally, this work explores the 
hypothesis that Tktl1 in mice and TKTL1 in humans modulates the activity of the PPP in 
a way that could contribute to neurodegeneration in ASD. Further, this work provides 
insight into the overall chromatin environment of the X chromosome allowing for 
analysis of previously unknown differences between the maternal and paternal X 
chromosome in mammals. 
Specific questions addressed in this dissertation include: 
 
1) Are nucleosomes positioned differently in a parent specific manner at the 
 
Xlr3/4 locus? 
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2) Are there parent-of-origin specific differences in open chromatin and thus 
different Transcription Factor (TF) binding motifs at the Xlr3/4 locus? 
3) Is TKTL1 expressed significantly different among Autistic and neurotypical 
brain sub-regions? 
4) What is the functional relationship between Tkt (the canonical mammalian 
transketolase) and its X-linked paralog, Tktl1 and how do they influence the 
Pentose Phosphate Pathway (PPP) in neuronal cells? 
4  
 
 
Background 
 
Autism Spectrum Disorder (ASD) 
 
A prevalent gender bias has been observed in several neurodevelopmental 
disorders and, of particular interest, in ASD. A 5:1 male to female ratio has been 
reported by the CDC, and in several studies a ratio as high as 7:1 has been seen in 
high-functioning ASD subjects7. The prevalence of ASD is approximately 1 in 59 
children in the US and between 1-2% worldwide according to the CDC data and 
statistics. From genome-wide association studies (GWAS) and exome and whole- 
genome sequencing of simplex and multiplex families with autistic individuals, both rare 
and common variants in over 100 genes have been implicated in the etiology of ASD8. 
Along with genetic factors, environmental factors are believed to play a significant role 
in the development of ASD9. At a cellular level, oxidative stress has been implicated as 
a contributing factor in ASD development stemming from a link between increased 
intracellular free radicals and neurodegeneration10. 
The most recent description and differential diagnosis of ASD arises from the 
Diagnostic and Statistical Manual V (DSM-5), since its release in 201311. The disorder 
typically manifests in symptoms including impaired communication and social 
interactions. The Autism Society also lists the following characteristics as 
signs/symptoms of ASD: lack or delay in spoken language, repetitive use of language 
and/or motor mannerisms, little or no eye contact, lack of interest in peer relationships, 
lack of spontaneous or make-believe play, and persistent fixation on parts of objects12. 
Currently, early intervention behavioral testing can significantly improve autistic 
individual outcomes by conducting a developmental screening of infants and working 
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with multidisciplinary teams to identify the needs of the child. However, understanding 
the underlying genetic component of ASD could lead to earlier intervention and 
potentially pharmacologic therapy targeted to the disorder. 
Neurons due to their high metabolic rate and reduced ability for cellular 
regeneration, are particularly sensitive to oxidative stress compared to other organs and 
cell types. This susceptibility to damaging effects of reactive oxygen species (ROS) has 
linked oxidative stress and neurodegenerative disorders such as Alzheimer’s disease 
and ASD. Ultimately, an increase in ROS leads to lipid peroxidation and the breakdown 
of cellular membranes13. Particularly of interest to this work is the function of 
transketolases during the non-oxidative phase of the PPP. Transketolase catalyzes the 
reversible conversion of glucose-6-phosphate to ribulose-5-phosphate in the non- 
oxidative phase of the PPP, and as a consequence, is responsible for the production of 
NADPH. NADPH production is essential for ROS protection in neuronal cells. 
Transkeolase activity in the PPP, therefore, may play a pivotal role in managing 
oxidative stress and, by extension, ensuring proper neurodevelopment14,15. 
As stated before, potentially contributory variants in over 100 genes have been 
linked to the occurrence of ASD. Genes that have been linked to ASD include; RELN, 
important for intercellular connections in the nervous system16, HOXD117, important for 
brain structure formation, genes involved in the production of Gamma-amino-butryic 
acid (GABA), an important neurotransmitter18, and SLCC6A4, a serotonin transporter 
gene important for serotonin equilibrium in synapses18. The gene, HOXA1 has been 
well studied and is essential to the development of cranial nerves, brain structures and 
the skeleton of the head and neck. Ingram et al. showed that a variant form of the 
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HOXA1 (A/G) gene occurred at a frequency of approximately 40% in ASD patients 
compared to the frequency of 10-25% in neurotypical individuals of European and 
African origin. Interestingly, this HOXA1 variant gene of interest displayed a gender 
effect of 11:10 (A/G to A/A) in females and 23:44 in males. It is suggested by Ingram et 
al. that this HOXA1 variant effect may be more apparent in females than males, where 
all affected females were A/G variant heterozygotes17. A statistically significantly larger 
proportion of affected offspring inherited the maternal G allele. It was concluded from 
segregation data that the parental source of the allele is important in the occurrence of 
ASD19. 
The sex differential in the HOXA1 variant association with ASD may be an 
example of what is termed, the Female Protective Effect (FPE) that was formulated to 
explain the sex bias in occurrence of ASD and other neurodevelopmental diseases20,21. 
The underlying theory of the FPE is that females have an inherent defense against 
certain disorders due to the action of sex hormones, or to the presence of two X 
chromosomes compared to the single X in males (paired with a Y chromosome). It has 
been reported that females diagnosed with ASD display numerous de novo DNA 
mutations compared to males21. In essence, for females to present an ASD phenotype, 
the threshold for ASD manifestation is higher. This protection may result from X 
chromosome mosaicism due to mammalian dosage compensation via X chromosome 
inactivation (XCI). XCI in karyotypically normal females constitutively silences one 
randomly chosen X chromosome, the resulting mosaicism in females provides a built in 
defense mechanism for detrimental recessive X-linked mutations21. If a predisposing 
variant is inherited by a female on a single X chromosome, only approximately 50% of 
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cells would ultimately express the variant, while males carrying the variant would 
express it in all cells. In this way, the female is protected from potential region specific 
deleterious effects of variant alleles. 
Evidence of a Social Cognitive Deficit Associated with X Chromosome Parent of 
Origin 
 
The FPE could begin to explain the occurrence of the male bias in ASD. Females 
would be inherently protected from social cognitive deficits associated with the X 
chromosome due to random X inactivation. Another theory proposed to explain why 
there is a high prevalence of ASD in males is the Extreme Male Brain (EMB) theory20. 
Baron-Cohen et al. hypothesize that autism is a manifestation of hyper-masculinized 
brain development. EMB invokes the involvement of Fetal Testosterone (fT), where 
increased levels of fetal androgens affect sex differences in behavior, cognition, brain 
structure and function20. This theory would explain how females are protected from 
higher rates of ASD and why males are susceptible. However, currently no concrete 
evidence exists connecting increased androgen levels and patients with ASD. With this 
lack of evidence, it has been hypothesized that differences on the X chromosome, such 
as the epigenetic environment, may explain the skewed prevalence of males diagnosed 
with ASD. 
This X chromosome hypothesis was first suggested by Dr. David Skuse after 
studying females with Turner Syndrome2. Turner Syndrome is the result of either total or 
partial X monosomy and patients share several symptoms with those diagnosed with 
ASD22,23. Skuse tested the social cognitive function of TS females first via a first-stage 
screening survey, then neurological assessments2. These neurological assessments 
included the Weschsler Intelligence Scales for Children, the Weschsler Adult 
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Intelligence Scales-Revised and the Test of Everyday Attention for Children. These 
tests were scored and their results showed that females in the study that inherited the 
maternal X chromosome (45,XM) performed significantly worse than those females who 
inherited the paternal X chromosome (45,XP), (Figure 1). From these results, he 
suggested that an imprinted gene or gene cluster on the X chromosome could account 
for the parent-of-origin difference in TS social cognitive impairment, and, furthermore, 
could explain the skewed prevalence of ASD in males2. This was the first report in the 
literature to invoke an epigenetic explanation for the sex bias in ASD. 
 
 
 
Figure 1: Skuse et al. Social Cognitive Ability 
Graph of social cognitive ability of Turner Syndrome Females inheriting either 45,XM or 
45,XP compared to 46,XX and 46,XY individuals. The higher score on this test indicates 
lower social cognitive ability. 45,XM females displayed the lowest levels of cognitive ability 
while 45,XP individuals displayed similar social cognitive abilities to that of males. 46,XX 
females scored best on the social cognitive test. Adapted from Skuse et al, 19972. 
The Epigenetic Effect and ASD 
 
Epigenetics encompasses the study of hereditable gene expression changes that 
do not involve changes to the DNA sequence. Epigenetic effectors in mammals include 
methylation of cytosines at CpG dinucleotides, and biochemical modifications to 
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nucleosomal histone proteins such as acetylation, methylation, phosphorylation, and 
ubiquitination24. Each one of these epigenetic marks can influence gene regulation in 
the cell. The term “epigenotype” was first coined by C.H. Waddington to describe how 
external factors, such as the environment, can have an effect on an organism’s 
phenotype25. In addition to Skuse’s X imprinting theory, evidence of a strong 
environmental component to the overall susceptibility of ASD was identified in studies of 
both monozygotic and dizygotic twins26,27. In order to understand the influence of 
epigenetics on the development of ASD, it is important to consider epigenetic influences 
on gene expression in the broadest of sense. 
One of the earliest observations of epigenetic gene regulation came from studies 
of position effect variegation in the fruit fly, Drosophila melanogaster in which 
experiments showed that a gene’s proximity to densely packed regions, or 
heterochromatic regions, of the chromosome can influence the overall expression levels 
of the gene28. Heterochromatic DNA is characteristically inaccessible to transcription 
factors and are generally silent domains due to the conformation of the chromatin in a 
dense state28. Another epigenetic phenomenon observed in maize involves an 
interaction of two alleles where one allele causes heritable changes in the second allele, 
without changing the DNA sequence, this is referred to as a paramutation29. The earliest 
epigenetic phenomenon studied in mammals focused on the mechanism that regulates 
X chromosome dosage compensation between males and females. In this process, a 
random X chromosome in XX females is silenced to reduce the genomic content to 
equal the XY male30. The epigenetic marks associated with this silencing event are 
discussed later in the chapter. Finally, genomic imprinting is known to be regulated by 
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epigenetic marks determining parent-of-origin specific gene expression, which will be 
examined further in the following section31. 
Evolutionary Origin of Genomic Imprinting 
 
Genomic imprinting involves the differential expression of genes depending upon 
which parent contributed the allele, and is often termed Parent-Specific Gene 
Expression (PSGE). PSGE has been most often observed in mammals32 and in seed- 
bearing plants33. The relevance of genomic imprinting to neurodevelopment and 
behavior in mammals comes about through understanding how it evolved. The original 
rationale to explain the evolution of imprinted genes involved a theory of parental 
investment (PI) in relation to both the parent and the offspring34. This theory addressed 
the conflict that arises between each parent’s optimal PI into each mating34. In 
mammals, as in seed-bearing plants, the development of offspring is supported by 
physical resource input from maternal tissues, while the paternal input is purely genetic. 
A prevailing theory in the field, known as the Parent-Offspring Conflict model, or Kinship 
theory, addresses the issue that although parental genetic contributions are equivalent, 
the amount of resource investment into the development and growth of the offspring is 
unequal34. The paternal genome can evolve ways to exploit the maternal input, while 
the maternal genome counter-adapts. The Parent-Offspring Conflict model explains the 
observation that most paternally imprinted (silenced) genes are growth suppressors, 
while most maternally imprinted genes are growth enhancers34. Pomiankowski 
hypothesized that due to the maternal and paternal X pattern of inheritance, where the 
paternal X is always passed to the female offspring and the maternal X is passed similar 
to autosomes, the X chromosome is pre-adapted to be regulated by imprinting. This 
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theory addresses X-linked imprinting as a response to selection pressure differences 
between males and females. The hypothesis is based on the asymmetry of inheritance 
of the maternal and paternal X chromosome and provides insight as to how X-linked 
imprinting may have evolved differently than autosomal imprinted genes following the 
Parent-Offspring Conflict model35. 
The fact that the parental genomes display functional inequality, creates in 
essence a roadblock to asexual reproduction in mammals meaning both parental 
genomes are essential for the developing organism36,37,38. Parental marks established in 
the germ line on individual alleles are crucial for the proper expression of genes 
throughout development38. One of the first mammalian epigenetic marks identified was 
parent-specific differential methylation39. Differential DNA methylation marks are 
established in the parental germ lines and are reset in a sex specific manner in each 
subsequent generation40. 
In terms of evolution, the Parent-Offspring Conflict model argues that paternal 
alleles aim to increase the input of maternal resources into developing young to gain a 
competitive advantage for their offspring from that specific mating (i.e. more resources, 
bigger, stronger offspring). Maternal alleles however, aim to reduce resource output per 
litter or offspring to ensure future viable mating. A female is able to contribute her 
genomic material to all of her offspring through successive matings with several males, 
whereas the male genome aims to optimize the survival of the offspring from only his 
mating. In essence, paternal alleles evolved an epigenetic program to maximize 
maternal output from a single breeding, while maternal alleles regulate to spread 
resources over several matings41. The result of this evolutionary conflict is the silencing 
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of the maternal alleles of fetal growth enhancing genes and silencing of the paternal 
alleles for growth suppressing genes42. As discussed below, mutations affecting normal 
imprinted expression of these genes not only affect growth patterns, but also adversely 
affect neurodevelopment. 
Genomic Imprinting in the Context of Disease 
 
Errors in balancing the genomic conflict inherent between the maternal and 
paternal genome have been associated with several disorders43,44. Understanding how 
these disorders arise may provide insight into how imprinted loci can influence ASD 
development. Loss of genomic imprints leading to inappropriate activation or silencing 
of both alleles severely alter gene dosages and can result in deleterious effects for the 
developing organism. Prader-Willi Syndrome45 and Angelman Syndrome44 are often 
caused by a deletion event on human chromosome 15. This deletion specifically occurs 
at the 15q11-q13 region and depending upon which parental allele experiences the 
deletion, the symptoms are very different46. A deletion of genes on the paternal 
chromosome 15 is responsible for the development of Prader-Willi Syndrome and 
Angelman Syndrome is caused by a deletion of a gene on the maternal chromosome 
1547. Due to the parent of origin specific deletion in these disorders, it was theorized that 
an imprinted locus was interrupted on chromosome 1547. Further research revealed 
that, in a subset of cases, uniparental disomy was responsible for the disorders48. This 
is consistent with the theory that these diseases involve genomic imprinting because the 
individuals would inherit identical imprinting marks on both alleles thus disrupting normal 
PSGE. The imprinted gene primarily associated with Angelman Syndrome, UBE3A, is 
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an ASD candidate gene; furthermore, patients with Angelman Syndrome exhibit autistic 
features49. 
Genomic Imprinting and Behavior 
 
The influence of imprinted genes on behavior was investigated by Champagne et 
al. using a Peg3 knockout mouse model50. Peg3 is a maternally imprinted and 
paternally expressed gene on mouse chromosome 7 that is strongly expressed in the 
placenta and the developing organism. Behavioral changes were observed in Peg3 
mutant female mice as well as a disruption of reproductive success. This result was 
dependent on the genetic background of the maternal mouse. Characteristics displayed 
by the Peg3 mutant mice included lower olfactory discrimination, reproductive success, 
pup retrieval, and postpartum licking/grooming. The mutant offspring displayed 
impairment in both sucking and growth rate compared to wild type (WT). Interestingly, 
the group also observed an effect of Peg3 mutant mice on their non-mutant female 
offspring suggesting there is a mode of transmission of effects without transmission of 
the mutant allele. It is believed the behavioral differences in the mother caring for her 
pups is responsible for this mode of transmission50. A recent study led to the 
identification of a gene in mouse, pleckstrin homology-like domain family A member 
2 (Phlda2), that influences the hormones produced by the mother during pregnancy51. 
This gene negatively regulates a portion of the placenta and is dependent on dosage of 
Phlda2 in the offspring. Expression differences of this gene were observed to cause 
changes to the maternal hypothalamus and hippocampus during pregnancy and altered 
maternal care for pups after birth. Paternal silencing of Phlda2 caused increased 
nurturing of pups suggesting that paternal silencing of this gene evolved to increase 
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maternal care51. This study provides evidence for how genomic imprinting of genes can 
be directly linked to behavior. Furthermore, it provides evidence that imprinted genes 
are involved in Parent-Offspring conflict, where the paternal genome influences the 
maternal output of resources, such as nurturing, to ensure survival of offspring. 
With imprinted genes associated with behavior and Pomiankowski’s theory of a 
pre-adapted X chromosome for genomic imprinting, Skuse et al.’s theory of X-linked 
imprinted genes underlying the difference in social cognitive ability in TS female patients 
is supported by data found the literature. Identification of X-linked imprinted genes 
responsible for X-linked imprinting and the underlying imprinting mechanism, may 
provide insight into the direct link of X-imprinted genes and neurodevelopmental 
disorders. The following section describes current understanding of characterized 
mechanisms of autosomal genomic imprinting. 
 
Underlying Imprinting Control Mechanisms 
 
Since imprinted genes have been implicated in ASD, it is important to understand 
the underlying mechanisms that control this parent specific expression. The following 
describes what is currently known in the literature about two autosomal imprinted gene 
clusters and their regulation. The best characterized of these genes is Insulin like 
growth factor II (Igf2)52,53. This gene is maternally silenced and paternally expressed on 
mouse chromosome 7. The imprint was discovered after disruption of Igf2 expression 
by gene targeting in mice produced differing results depending on whether the knockout 
was transmitted through the maternal or paternal germ line. When Igf2 expression was 
altered in the paternal germ line, the resulting offspring displayed adverse 
characteristics52. However, this was not the case when the gene was altered in the 
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maternal germline52. This observation suggested that a parent specific expression effect 
may be occurring at the locus. Subsequently, a DMR was observed in the promoter of 
the gene H1953, which is closely linked to Igf2 on mouse chromosome 753. At this locus, 
the paternal allele is methylated while the maternal allele is unmethylated, and H19 
shows a pattern of PSGE opposite that of Igf253. Igf2 and H19 were observed to utilize 
the same enhancer elements downstream of H19 to regulate gene expression of 
opposing parental alleles53. The protein CTCF binds to the unmethylated maternal allele 
upstream of H19 and acts as an insulator allowing the enhancer elements to interact 
with the promoter and drive gene expression of H19. On the paternal allele, the region 
is methylated, CTCF cannot bind, and the enhancer elements are used by Igf2 to 
express the gene (Figure 2). To determine if this DMR was in fact the imprinting control 
region (ICR), deletion experiments were conducted to elucidate if expression of the 
parental alleles were altered54,55. It was concluded that the identified DMR was 
responsible for regulating proper imprinting at the locus54,55. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Igf2/H19 Imprinting Mechanism 
Methylation of CpG islands on the paternal allele of the Igf2/H19 locus. Due to this 
methylation CTCF is unable to localize and downstream enhancers loop 100kb to interact 
with Igf2. The ICR is unmethylated on the maternal allele allowing CTCF to bind upstream 
of the H19 promoter. CTCF acts as an insulator, preventing enhancers from looping back 
to transcribe Igf2 and instead drive expression of the non-coding RNA H19. 
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Differential methylation is one mechanism governing genomic imprinting at 
autosomal loci. Another mechanism involves the transcription of a long non-coding RNA 
transcript that can regulate imprinted expression56. One well-studied example of this 
mechanism is the transcription of a non-coding RNA, Airn, which regulates expression 
of the imprinted genes Igf2r, Slc22a2, and Slc22a357. Interestingly, a non-coding RNA is 
produced at the H19 locus, however, evidence shows this non-coding RNA is not 
responsible for establishing the imprint at the Igf2 locus58. To date, no sex-linked 
genomic imprinting mechanism has been identified. Understanding the underlying 
imprinting mechanism of X-linked genes could help explain the findings of Skuse et al. 
and provide insight into future therapies for X-linked imprinting disorders. 
DNA Methylation and DMRs 
 
Defects in DNA methylation have been implicated in disorders including cancer59 
and neurodevelopmental disorders such as schizophrenia60 and ASD61. Most commonly 
in mammals, DNA methylation involves the addition of a methyl group to the 5’ carbon 
of a cytosine residue by a DNA Methyltransferase (DNMT)62. As stated previously, DNA 
methylation is an epigenetic mark that can be altered to change the phenotype of an 
organism without changing the underlying DNA sequence. This mark is known to 
influence processes including X Chromosome Inactivation (XCI), carcinogenesis, and 
genomic imprinting by regulating DNA accessibility and regulating expression62. DNA 
methylation is common and in general occurs in the mammalian genome at 
approximately 1% of cytosines49. Typically, high levels of methylation are seen at what 
are called CpG islands. The generally accepted characteristics of a CpG island are 
regions where the observed to expected ratio of CG nucleotides is greater than 60% in 
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200 bp of sequence63. About 85% of the time, these CpG islands are located near the 
promoters and transcription start sites (TSSs) of genes. In the case of the Igf2/H19 
locus, differentially methylated transcriptional regulatory domains regulate gene 
expression in a parent-of-origin specific manner64,65. DNA methylation often blocks the 
binding of transcription factors, thus rendering the region silent66. During mammalian 
pre-implantation development, there is a wave of genome-wide demethylation followed 
by lineage-specific methylation that maintains cellular identity and genomic stability67. 
However, ICRs manage to remain methylated during this event in the developing 
embryo68. In this way, ICRs are preserved to regulate genomic imprinted loci and 
establish the baseline for parental allele differentiation. This process is maintained by 
DNA methyltransferase, Dnmt169. 
 
Mammalian Dosage Compensation 
 
The sex chromosomes are of particular interest in neurodegenerative disorders 
including ASD, which presents a sex bias in diagnosis frequency. Specifically, gene 
expression on the X chromosome is implicated in social cognitive deficiencies2. In 
mammals, males are the heterogametic sex with an X and Y chromosome. The 
evolutionary origin of the mammalian sex chromosomes is thought to be an autosomal 
pair that acquired a sex-determining trait70,71. When organisms are heterogametic for 
sex chromosomes with an unequal amount of genomic material, a method must evolve 
to normalize the transcriptional output between the two sexes72. This method is known 
as dosage compensation and this process has evolved differently in several organisms. 
For example, in Drosophila melanogaster, the male inherits only a single X 
chromosome. To equalize expression to the female (XX), the male upregulates gene 
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expression on the single X two-fold73,74. The nematode worm, C. elegans, utilizes a 
different dosage compensation mechanism: the hermaphroditic organisms (XX) reduce 
the expression of each X by half so as to equal the expression levels of the male with 
one X chromosome75,76. Important to this work, female mammals, accomplish dosage 
compensation by randomly silencing a single X chromosome in a process known as X 
Chromosome Inactivation (XCI)77. This process is required to balance the uneven 
genomic material present on two X chromosomes compared to the males X and Y. The 
Y chromosome in most cases is small and gene poor compared to the X 
chromosome78,79,80. 
X chromosome silencing actually occurs in two separate phases. First, a 
preferential silencing of the paternal X chromosome occurs in the preimplantation 
embryo81. This silencing is reversed in the early blastocyst and both X chromosomes 
are once again active82. After this point, to accomplish dosage compensation by XCI, 
the silencing mechanism first begins at a region known as the X chromosome 
inactivation center83. The number of X chromosomes are counted within the cells by 
molecular machinery to begin XCI84. The long non-coding RNA transcript Xist then 
begins to be produced by the X chromosome randomly selected to be silenced. On the 
active X chromosome, the antagonistic long non-coding RNA Tsix is produced 
preserving the active status of the allele85,86. The silenced X chromosome is condensed 
into a heterochromatic state by the Xist transcripts coating the chromosome and 
recruiting epigenetic modification to render it inactive. The inactive X chromosome is 
referred to as the Barr Body which remains inactive and locates to the periphery of the 
cell87,88. Interestingly, the overall methylation between the silenced and active X 
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chromosomes remains the same, however, CpG islands on the silenced X are shown to 
be hypermethylated89. This hypermethylation of CpG islands should silence 
transcription at normally active genes. Evidence has shown that histone H2A.1 is 
essential for XCI and is preferentially loaded into nucleosomes on the inactive X 
chromosome to ensure a persistent silent state90,91. This is one line of evidence of 
nucleosomes, and histone proteins influencing gene expression on the X chromosome. 
The random inactivation of either of the two parental X’s in female eutherian 
mammals during XCI means that normal females are mosaics, carrying groups of cells 
differentially expressing a parental X in all tissues92. However, during fetal development, 
the placenta preferentially silences the paternal X while the maternal X remains active93. 
Interestingly, marsupials preferentially silence the paternal X in all tissues throughout 
the life of the organism94,95. 
While autosomal imprinted genes are expressed equally between sexes, X 
inactivation results in an additional layer of complexity in terms of genomic imprinting. 
Skuse et al. and Raefski et al. explained that X-linked imprinted genes are not believed 
to be expressed equally between the sexes2,5. Due to the unequal expression of genes 
on the sex chromosomes, a maternally silenced X-linked gene would not be expressed 
in males. Conversely, a maternally expressed/paternally silenced X-linked imprinted 
gene would be expressed in all male cells while only in half of the cells in females due 
to XCI mosaicism. This would lead to higher expression of maternally expressed and 
paternally silenced genes in males compared to females. Having this imbalance of gene 
expression from genomic imprinting could result in sex specific differences96,97,98,99. 
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Raefski Development of Turner Syndrome Model Mice 
 
Raefski and O’Neill utilized a TS mouse model to generate X monosomic mice 
where the X chromosome parental lineage could be tracked and studied3. The Patchy 
Fur (Paf) strain caries a large inversion on the X chromosome leading to a high 
frequency of sex chromosome non- 
disjunction during meiosis in 
spermatogenesis. Male Paf mice mated 
with wild type C57 female mice produce 
39,XM genotype in 25% of progeny. The 
InX strain also carries a large X inversion 
that leads to non-disjunction of the X’s 
during oogenesis. C3H/InX female mice 
bred with a wild type C57 males 
produces a 39,XP genotype 
approximately 20% of the time (Figure 
Figure 3: X Monosomic Mouse Breeding 
Scheme 
Breeding generated 39,XM ~25% of offspring 
and 39,XP ~20% of offspring 
3) (the C3H/InX hybrid females are used to distinguish XC3H/XC57 or XInX/XC57 females 
from monosomic XC57 females)5. 
Using neonatal brain RNA from these monosomic mice to perform a 
transcriptomic screen, a gene cluster at XA7.2 was identified to be imprinted, 
comprising three paralogs of the X-Linked Lymphocyte Regulated (Xlr) family of genes. 
Subsequent experiments showed that this imprinted locus was not regulated by a DMR 
and further experiments were conducted to investigate the underlying imprinting 
mechanism of the Xlr locus. To date, no sex-linked imprinted genes have been shown 
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to be regulated by a DMR suggesting that a novel imprinting mechanism exists for the 
Xlr imprinted cluster(86,89,91,92). The Xlr imprinting cluster and underlying imprinting 
mechanism will be discussed further in the following chapters. 
After the initial discovery of the Xlr imprinted locus, Dr. Inga Nesbitt screened 
surrounding genes on the mouse X chromosome to identify other potentially X-linked 
imprinted loci. A candidate gene was identified downstream of the Xlr cluster, 
Transketolase-Like 1 (Tktl1), that displayed a partial imprint in both olfactory bulb and 
neonatal neocortex. Follow-up experiments investigating the imprinting status and 
function of Tktl1 and its human ortholog TKTL1, its imprinting status, and overall 
function will be addressed further in the following chapters. 
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Chapter 2: The Imprinted X-Linked Lymphocyte Regulated Locus (Xlr) 
 
Characterization of the First X-Linked Imprinted Locus (Xlr) 
 
The dosage compensation mechanism of the sex chromosomes in mammals 
presents an additional layer of complexity to parent specific effects. For this reason, in 
many published GWAS and genetic linkage studies the X chromosome is frequently 
ignored100, leaving a gap in knowledge surrounding sex-linked imprinted genes. Until 
2005, imprinted genes on the X chromosome had yet to be identified in mammals. 
Publishing back-to-back in the same issue of Nature Genetics, Raefski and O’Neill, 
along with Davies et al. published the discovery in mice of the imprinted gene Xlr3b5,99. 
While Davies only identified this one gene, Raefski was able to determine imprinting 
status of two additional closely linked genes, Xlr4b and Xlr45. The Xlr genomic 
organization at this region consists of three triads, Xlr3a/b/c, Xlr4a/b/c and Xlr5a/b/c. 
Only three of the nine genes in this cluster have been identified as imprinted, and no 
other member of the Xlr superfamily displays evidence of genomic imprinting. As 
discussed in the previous chapter, Dr. Raefski utilized a TS mouse model to generate X 
monosomic mice to examine the expression levels on the individual parental X 
chromosome employing a gene expression microarray screening approach. Using these 
mice, he determined all three imprinted genes are maternally expressed and paternally 
silenced in mouse neonatal brain (Figure 4), and later showed this pattern in mouse 
primary fibroblast cells (data not shown). 
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Figure 4: Discovery of the Imprinted Xlr3/4 Region 
Real-Time PCR results of 40,XX, 39,XM, 39,XP, and 40XY mouse transcripts identifying 
genomic imprinting of the genes Xlr3b, Xlr4b, and Xlr4c. Maternal X expression and paternal 
X silencing is noted. Raefski and O’Neill 20053. 
 
There are multiple clusters of Xlr genes scattered across the rodent X 
chromosome. All Xlr genes are derived from the single copy autosomal gene 
Synaptonemal Complex Protein 3, Sycp3. Sycp3 plays a critical role in meiosis, 
comprising the axial elements of the synaptonemal complex101. While Xlr-like gene 
clusters have been identified on most of the sequenced X chromosomes of eutherian 
mammals, the only Xlr-like genes found in primates are the FAM9 genes located at the 
human Xp22.3 region. While the Xlr3/4/5 cluster is specific to rodents, the Xlr3/4 genes 
have homologs on the X chromosomes of elephant, dog, and swine, suggesting that 
Xlr3/4 are the most ancient members of the Xlr superfamily. The Xlr3/4/5 triad is present 
in five closely linked copies with their orientation suggesting segmental duplications are 
responsible for the multicopy organization of the genes102. The Xlr3, Xlr4, and Xlr5 
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genes share approximately 30% sequence similarity in protein-coding regions. All 
paralogous Xlr3 copies code for nearly identical proteins and share a coding nucleotide 
sequence similarity over 90%. The extremely high sequence conservation of the Xlr3 
paralogs is also true for the Xlr4 and Xlr5 paralog groups, respectively. 
 
 
 
Figure 5: X-Linked Lymphocyte Regulated (Xlr3/4) Locus 
Illustration of the X‐linked Lymphocyte Regulated (Xlr) locus at XA7.2 (mm10). Red indicates 
imprinted genes. 
 
 
Functional Study of the Xlr3b Protein 
 
Most research about the Xlr3/4 region revolved around the characterization of the 
imprinting mechanism regulating gene expression at the locus. More recently, work 
conducted by R. Foley in the O’Neill lab aimed to elucidate the function of the protein 
products of the Xlr3 paralogs103. Utilizing amino acid alignments to visualize protein 
domains, Xlr3b was observed to contain a so-called COR1 domain. The COR1 domain 
has an unknown function, but is conserved in the Synaptonemal Complex Protein 3 
(Sycp3) protein104,105. During meiosis, homologous chromosomes exchange genetic 
information during crossing over before segregation and this process is regulated by the 
Synaptonemal Complex (SC). Due to the shared COR1 domain between Xlr3b and 
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Sycp3 and the fact that Xlr3 mRNA is highly expressed in testis, Dr. Foley investigated 
the potential role of Xlr3b in spermatogenesis and meiosis. 
While quantitative real-time PCR (qRT-PCR) showed expression of the Xlr3b 
transcript as early as spermatogonial stages, Western blot analysis using an antibody 
that recognizes all XLR3 protein products showed expression of the XLR3 protein first 
detected during early prophase of meiosis I. Spermatocyte and embryonic ovary cell 
surface spreads were used to view the localization of the XLR3 protein by 
immunohistochemistry (IHC). In meiotic oocytes, XLR3 was observed localizing to 
Nuclear Organizing Regions (NORs). During spermatogenesis, XLR3 was observed 
localizing to the XY body, a compartment in the meiotic prophase I nucleus containing 
the inactivated X and Y chromosomes. Compartmentalization and inactivation of the X 
and Y chromosomes occurs in male meiosis and is referred to as Meiotic Sex 
Chromosome Inactivation (MSCI). While the role of XLR3 in MSCI is currently 
undefined, Sycp3 is known to play an essential role in the establishment of MSCI. 
 
Regulation of the Imprinted Xlr Cluster 
 
Investigating the imprinting mechanism of the Xlr3/4 cluster may provide insight 
into how parent specific expression on the sex chromosomes is regulated at other as 
yet unidentified loci. As stated previously, the majority of autosomal imprinted genes are 
regulated by Imprinting Control Regions (ICRs), typically demarcated by a differentially 
methylated region (DMR) governing the chromatin state of the parental alleles. Using 
this as a starting point, a former member, B. Carone, attempted to identify a DMR 
regulating the Xlr3/4 locus106. DNA methylation was analyzed via bisulfite sequencing of 
predicted CpG islands in a ~250 kilobase region including the three non-pseudogenous 
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Xlr3/4/5 clusters (i.e. all of the A, B, and C paralogs). The results, as shown in Figure 6, 
showed hypermethylation at both the non-imprinted and imprinted paralogs of both 
parental alleles. 
 
 
 
Figure 6: Methylation Status at the Xlr Imprinted Cluster 
Bisulfite sequencing analysis results of CpG island clones associated with the Xlr 
paralogs. Unmethylated CpGs are unfilled (white) “lollipops” while methylated are 
filled in black. Figure from Carone, 2008. 
Following these results, the search expanded to regions further up and 
downstream of the Xlr3/4 cluster. ICRs are known to regulate distal parental expression 
of genes such as in the Igf2/H19 imprinted region. In fact, approximately 90kb of 
sequence separates the ICR of this locus and the Igf2 promoter107. To investigate distal 
regions, M. Murphy of the O’Neill lab conducted immunoprecipitation of methylated DNA 
from monosomic neonatal brain samples (MeDIP) followed by hybridization to 
Affymetrix tiling arrays of the mouse X chromosome108. While MeDIP identified a 
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potential DMR upstream of Xlr3b this result could not be replicated by bisulfite 
sequencing (data not shown). 
In the absence of a detectable DMR, S. Kasowitz of the O’Neill lab investigated 
the Xlr3b primary transcript to determine if PSGE was achieved by a co- 
transcriptional/RNA processing mechanism109. He noted that while Xlr3b equally 
initiates transcription equally from both parental alleles, by exon 7, the transcript on the 
Figure 7: Xlr3b Primary Transcript Analysis 
qRT-PCR of Xlr3b primary transcripts assayed at varying locations in the gene body. 
Uniform 39,XM primary transcript compared to lack of transcript on 39,XP allele in neonatal 
brain at Intron 7. Figure from Kasowitz, 2011. 
 
 
paternal allele is virtually undetectable via qRT-PCR (Figure 7). This would mean some 
mechanism interrupts proper transcription elongation on the paternal allele. Conversely, 
a mechanism may exist that removes an obstacle to transcription elongation on the 
maternal allele allowing for the full transcript to be produced. 
To determine if PSGE of Xlr3b is governed at the level of transcription elongation 
or transcript processing, former O’Neill lab member S. Qureshi investigated the 
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chromatin architecture and RNA Polymerase II (RNA Pol II) occupancy on the maternal 
and paternal alleles of Xlr3b by performing Chromatin Immunoprecipitation on 
neocortex of monosomic neonatal mice. RNA Pol II was equally enriched on both 
parental alleles at the 5’ end of the Xlr3b transcription unit. However, a peak of 
enrichment of the Serine 2-phosphorylated RNA Pol II (actively elongating) was 
observed on the paternal allele at the Intron3/Exon4 boundary compared to the 
maternal allele. At intron 7, Ser2-RNA Pol II was more enriched on the maternal allele. 
This data is in agreement with the primary transcript qRT-PCR, and suggests that 
transcription is initiated on both alleles, but that elongation stalls somewhere in the 
middle of transcription on the paternal allele. It is important to note that the paternal 
allele-specific RNA Pol II stall at Intron3/Exon4 revealed by these ChIP experiments has 
not been replicated in further experiments. Therefore, the molecular nature of the Xlr3b 
imprint is still unknown. 
Dr. Foley set out to investigate differential methylation in surrounding regions of 
the imprinted cluster, particularly the methylation status of Factor 8 associated gene A 
(F8a). In doing so, he opened the door to a potential DMR residing directly within the 
imprinted cluster itself. Dr. Foley was first interested in F8a when ENCODE released 
ChIP data observing CTCF binding motifs within the 5’ end of F8a. The very same 
insulating protein present at the most well studied imprinted locus, Igf2/H19, was 
positioned within the Xlr imprinting cluster of genes. CTCF is known to create chromatin 
loop structures to orchestrate enhancer/promoter interactions and also functions in 
important regions as an insulator. Also of note, the ENCODE tracks identified a p300 
known enhancer flanking the CTCF site in F8a. These CTCF binding sites reside within 
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the F8a gene body along with a CpG island that was not previously investigated by 
former lab members. In fact, a portion of the CpG island was indeed analyzed, but did 
not incorporate the CTCF binding sites. 
Dr. Foley decided to investigate the methylation status of this CTCF binding site 
associated with the CpG island. His results can be found in Figure 8 and depict 
differential methylation with a methyl sensitive PCR assay. Dr. Foley found that 
surrounding the CTCF binding site were differentially methylated CpG’s where XM was 
hypermethylated and XP was hypomethylated. Using bisulfite sequencing he 
determined a subtle methylation difference of approximately 4% differentiated the 
maternal and paternal allele. To explore whether this DMR located in F8a regulated 
Xlr3/4 expression, he performed a 
CRISPR deletion of the CTCF 
binding site. However, no effect 
was observed on the overall 
imprint. Work conducted to 
further understand this 
functional mechanism 
regulating Xlr3/4 will be 
discussed in the following 
chapters. 
 
 
Figure 8: HpaII Methylation Assay at F8a 
HpaII sites in neonatal whole brain analyzed. HpaII 
cutting at sites would produce no band 
hypomethylation. No cut would produce positive band 
and indicate hypermethylation. 
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Chapter 3: Chromatin Architecture at the Imprinted Cluster Xlr3/4 
Region 
Bionano Methylation of XA7.2 
 
Thus far a novel X chromosome imprinting mechanism has yet to be discovered. 
As discussed in the preceding chapter, previous members of the O’Neill lab assayed the 
CpG island methylation status of regions surrounding the Xlr3/4 imprinted genes via 
bisulfite sequencing and MeDIP/microarray and found no differential methylation. Dr. 
Murphy’s MeDIP initially identified a differentially methylated region upstream of Xlr3b 
but subsequent bisulfite sequencing of this site revealed no allele-specific methylation. It 
has been shown in previous studies such as the investigation of the H19/Igf2 locus that 
it is not required for a DMR to be proximal to the imprinted gene. The genes Igf2 and 
H19 are approximately 70 kb apart and are regulated by the same DMR110. 
Concerns in the O’Neill lab that previous methylation screens were insufficient to 
identify distal DMRs motivated a series of follow up experiments utilizing a new 
approach. To accomplish a wide range methylation profile of the XA7.2 region and also 
the entire X chromosome, an assay was developed for the Bionano Genomics Irys 
platform. The Bionano platform utilizes nanochannel technology in coordination with 
restriction enzyme cut site fluorophore incorporation to be read by a laser within the 
instrument. The general purpose of the Irys is to create large molecule (≥150 kb) 
fragments to be aligned to a restriction enzyme digested genome to create a scaffolding 
backbone for assembly and sequencing analysis111. Expanding on this concept, the 
laboratory of Dr. Yunal Ebenstein in Tel Aviv developed a methylation detection protocol 
to be used on the Bionano Irys system. In collaboration with the Ebenstein lab and the 
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laboratory of Dr. Elmar Weinhold in Germany, I modified the Bionano Genomics 
protocol to enable visualization of methylated sites with the Irys system111,112. 
 
 
 
 
Figure 9: Bionano Methylation Assay Alignment 
Bionano methylation sensitive assay aligned to a CMAP file for BspQI (Bionano supplied 
enzyme). Bionano molecule alignment analysis with IrysView software from Bionano 
Genomics of genomic region ChrX:73,000,000-73,750,000 containing Xlr imprinted cluster 
(A.) and genomic region ChrX:100,000,000-103,600,000 (B.) representing a higher quality 
molecule alignment with the software. Xlr3b is highlighted in the blue boxes on the maternal 
and paternal alleles. Due to shearing events caused by the additional methylation steps of 
the protocol, molecule alignment results were lower than expected. The software needed to 
allow for smaller fragments causing lower mapping rates. XM mapping 28.1% of molecules 
and XP mapping 14.3% of molecules. 
39,XM and 39,XP samples were prepared with the Bionano Prep Blood and Cell 
Culture DNA Isolation Bundled Kit following the Bionano Genomics protocol for high 
molecular weight DNA isolation. Samples were labeled with the cofactor AdoYnCF640R 
(gift from Dr. Elmar Weinhold lab)113 with M.TaqI followed by knick labeling with 
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Nt.BspQI enzyme as a part of the Bionano NLRS protocol. M.TaqI is a 
methyltransferase enzyme with a recognition site, TCGA. M.TaqI methylates the 
adenine residue within this sequence, and can be used to incorporate a labeled 
cofactor. However, if the CpG within the recognition sequence is methylated, the 
reaction is blocked114. Samples were run on the Bionano Irys instrument and images 
were captured and interpreted by the Bionano Irysview software package. A molecule 
quality report was produced for high molecular weight molecules and alignment to the 
digested mm10 reference genome (CMAP) was performed, followed by mapping 
assembly. Molecules were mapped by matching of restriction digest labeled regions 
incorporated via the Nt.BspQI restriction enzyme provided by Bionano Genomics. In this 
way, large DNA molecules are knick labeled at known restriction enzyme digest regions 
of the genome and fragments are aligned based on distance calculated between 
incorporated labels viewed in the nanochannel. Molecules depicted in Figure 9 show 
these alignment to the reference genome. In (A) the Xlr3/4 region is visualized with 
minimal coverage by large DNA molecules and in (B) a different region of the X 
chromosome is shown with higher coverage. The tool utilized by the Ebenstein lab to 
analyze the incorporated methylation fluorophore, Irys Extract, requires deeper 
coverage, and thus visualization of the methylation status on the X chromosome was 
unable to be accomplished with this platform. 
Images generated by the Irys Extract software would have allowed visualization 
of the fluorescently labeled DNA molecules for a given chromosomal region. Had this 
assay produced non-sheared DNA molecules, Irys Extract could have identified which 
molecules mapped to the reference genome at the Xlr3/4 locus and provided insight into 
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the methylation status between the maternal and paternal alleles. The molecules were 
stained green for the Nt.BspQI restriction sites and red for methylated cytosines by 
M.TaqI. Without high quality large DNA molecules, a sufficient Molecule Quality Report 
could not be generated for the data to allow for further analysis. 
DNA was sheared due to the additional step of labeling the molecules with the 
methylation sensitive cofactor AdoYnCF640R. Shearing was determined by the average 
length of DNA fragments being <150 bp during analysis. This resulted in fewer 
molecules mapped to the reference and minimal coverage across the genome as seen 
in Figure 9. The methylation status across the X chromosome environment remains 
elusive and awaits further analysis. DNA handling steps for future methylation sensitive 
assays should be minimized to reduce potential shearing. Simply adding one additional 
mixing step was enough to shear DNA molecules. If more pervasive information about 
the overall methylation environment of the X chromosome is desired, I would not 
suggest using the Bionano Genomics platform for future studies. The Nanopore MinION 
could be used to discern differences in DNA methylation across the X chromosome. 
This technique utilizes bioinformatics tools to identify differing ionic current signals on 
methylated versus unmethylated cytosines and adenosines114. 
 
Nucleosome Positioning at XA7.2 
 
Chromosome composition can affect transcription by influencing the ability of 
transcription initiation and elongation by RNA Pol II115. Nucleosomes present a physical 
barrier that can cause backtracking/arrest of RNA Pol II during active transcription and 
are known to regulate the access of cellular transcription machinery to DNA loci116. 
Typically, the transcription machinery can overcome this arrest by the incorporation of 
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specific functional histone variants. Nucleosome rich regions are difficult for RNA Pol II 
to transcribe through and are often associated with RNA Pol II strand dissociation, 
meaning a dense region of nucleosomes near the Xlr3b intron3/exon4 boundary could 
explain the stalling event previously seen on the paternal allele117,118. 
ChIP analysis by S. Qureshi in the O’Neill lab appeared to reveal an RNA Pol II 
stalling event during transcription of the Xlr3b gene on the paternal allele. Dr. Qureshi 
also found enrichment of H3K36me3 at the precise location of the RNA Pol II stalling 
event on the paternal Xlr3b via ChIP. Dr. Qureshi’s ChIP results formed the rationale for 
experiments to map nucleosome positioning at the Xlr3/4 locus. MNase-Seq was used 
to investigate nucleosome positioning in the Xlr3/4 region. However, recently Dr. 
Qureshi’s data has not been able to be replicated by current members of the lab. While 
the stalling event is now in question, the following nucleosome positioning assays were 
conducted with the RNA Pol II stalling hypothesis in place. 
Analysis of Nucleosome Positioning by MNase-Seq 
 
Nucleosome positioning and occupancy has been implicated in influencing gene 
expression by impeding transcription in various ways. It has been shown that 
nucleosomes can inhibit activator binding and the formation of the preinitiation complex 
(PIC) as well as preventing proper elongation in transcription119. Micrococcal nuclease 
is an enzyme used to digest double-stranded, single-stranded, circular and linear 
nucleic acids. In particular micrococcal nuclease is unique due to its ability to cause 
double stranded breaks and digestion of nucleosome linker regions while leaving the 
nucleosome region intact120. Utilizing the function of this enzyme, nucleosome positions 
are able to be determined. Genome-wide nucleosome occupancy maps (NOMs) have 
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been developed121; the X chromosome, however, often presents unique challenges to 
allele specific experiments and the data tends to be unreliable due to the additional 
complexity of X inactivation and heterogametic sex chromosomes. Using the 39,XM and 
39,XP Mus. musculus TS model mice, I was able to sequence the single X chromosome 
and compare the nucleosome profile between the maternal and paternal X 
chromosome. 
Neocortex brain tissue was extracted from neonate 39,XM and 39,XP Mus 
musculus neonates and chromatin was isolated in biological triplicates. Micrococcal 
nuclease was used to digest double stranded DNA not bound to histone proteins and 
DNA fragments were target enriched using cRNA baits specific to the XA7.2 region of 
the mouse X created from Agilent SureSelect probes122. Library construction was done 
for the Illumina MiSeq platform and produced paired end 150 bp reads after adapter 
sequence trimming. Fasta and Fastq files were produced and a FastQC quality report 
was generated to assess read quality (Appendix Figure 1). Paired end reads were 
aligned and indexed to the mm10 Mus musculus genome using Bowtie2. 
Many short read mappers could be used such as BWA and Bowtie2123. Bowtie2 
was used for this experiment because of the use of genome indexing, a computational 
strategy utilizing a Burrows-Wheeler transformation to speed up the alignment 
algorithm. This indexing technique can compress a reference genome to save memory 
while still enabling efficient read alignment. Bowtie aligns each read one base pair at a 
time to the Burrows-Wheeler transformed genome until alignment of the entire read is 
accomplished. This mapping algorithm, although much more complicated than others, 
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has been shown to be up to 30 times faster enabling high quality mapping in less 
time124. 
Unique mapping is achieved in Bowtie2 by passing nucleotide mismatches and 
quality parameters to allow a single read to map to one location in the genome. This 
unique mapping is part of the default parameters of Bowtie2. Due to the high sequence 
similarity of the paralogous Xlr family of genes, unique mapping would result in the 
exclusion of nearly all reads in the region that do not contain a paralog specific single 
nucleotide polymorphism (SNP). Due to this, a different non-unique mapping approach 
was required for analysis of the MNase-Seq data. Since paralog specificity could not be 
achieved by this approach, any differences observed between the parental alleles are 
assumed to be associated with the imprinted paralog. Biallelically expressed paralogs 
would likely not display differences between parental alleles whereas monoallelic 
expression would be accomplished by differences between the parental alleles. All 
reads were called, mapped and then visualized in IGV125,126 for a profile of nucleosome 
occupancy across the Xlr3/4 region, creating a nucleosome map across the paralogs. 
With the high sequence similarity, normalizing the reads was essential to examine the 
differential enrichment of nucleosomes between 39,Xm and 39,Xp neocortex brain 
samples. This was achieved utilizing the R package normR127. Bam alignment files and 
indexed files were imported into R and treated as control (39,Xm) and treatment (39,Xp). 
I hypothesized that 39,Xp would have differential nucleosome positioning interfering with 
successful RNA Pol II transcription through the gene body. 
Mapping was followed by data analysis with R packages including nucleR, PING 
and normR127,128,129. NucleR compiles all reads and filters with a threshold peak calling 
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of 25% and creates a bed file output that can be visualized on the UCSC Genome 
Browser. Additionally, PING was used to display a nucleosome occupancy map (NOM) 
providing a graphical depiction of the nucleosome positioning data in a designated 
genomic frame. This analysis processes the reads of a specified size and uses a peak 
detection script creating a peak score determined by a 25% threshold. Figure 10 depicts 
the NOM of Xlr3b across the 39,XM and 39,XP gene body generated by PING. Finally, 
normR was used to normalize reads between the sample sets. Numerically identified 
neonate samples XM73, XM86, XM91, XP100, XP148 and XP175 were concatenated into 
large XM and XP BAM files for this portion of the analysis. NormR utilizes a script to 
normalize reads between two data sets against background. DiffR is a script in the 
normR package that can be used for enrichment analysis in ChIP-Seq and alike 
datasets and here was used to determine enrichment of reads between XM and XP 
samples. The read counts are modeled as a binomial mixture model, meaning the 
datasets were analyzed for the presence of differing sub-regions and applied to a 
binomial distribution. Significance was set in the script to P ≤ 0.001 and all remaining 
reads were depicted in an output BED file and visualized in IGV (Figure 11). 
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Figure 10: MNase-Seq Nucleosome Occupancy Map (NOM) 
Nucleosome occupancy map for Xlr3b generated from MNase sequencing reads from 
39,XM and 39,XP neocortex samples. Reads generated from MNase-Seq treated 
samples and run on Illumina Mi-Seq Overall profile of nucleosome occupancy peaks 
similar between XM and XP. R package PING used to generate occupancy maps. 
Output threshold 25% peak calling per package guide. All graphs from 
ChrX:73192179−73202930 to depict Xlr3b in mm10. 
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Figure 11: MNase-Seq Data Analysis 
Nucleosome occupancy enrichment at the imprinted Xlr locus, F8a and Spin2d (both 
biallelically expressed). Blue bed file bars represent enrichment of nucleosomes on the 
paternal allele while red represent enrichment of nucleosomes on the maternal allele 
Enrichment analysis done in R with normR package and diffR script. All enrichment had 
a p-value of p=0.001. 
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An enrichment of nucleosomes on the 39, XP allele is observed juxtaposed to the 
stalling event initially seen by Dr. Qureshi. Additionally, this enrichment includes a 
portion of SINE-B4 element associated with imprinted genes in mouse. SINE-B4 
elements have been shown to be enriched in maternally active and paternally silenced 
imprinted gene loci130. The presence of this known associated repetitive element 
coupled with enrichment of two nucleosomes positions of the paternal allele within this 
SINE-B4 element could be associated with an imprinting control mechanism on the X 
chromosome. 
Where there has been no discernable differential methylation in the region of the 
Xlr3/4 imprinted cluster, some other mechanism must be controlling the expression 
status of these alleles. A potential RNA Pol II obstacle in the form of enriched 
nucleosomes on the paternal allele could govern the expression of the Xlr imprinted 
genes. Very few differences between the alleles have been identified previously, and 
this statistically significant difference highlighted in Figure 11 in the green boxes could 
very well be associated with an imprinting control mechanism on the X chromosome. 
Nucleosomes prevent the progression of RNA Pol II productive elongation on the 
paternal allele by creating a physical barrier to the transcription machinery. RNA Pol II 
machinery has been shown to stall and dissociate from genomic regions in previously 
reported experiments131. 
This MNase-Seq experiment was a critical step in identifying differential 
nucleosome positioning at the Xlr3/4 locus. However, due to the use of Agilent 
SureSelect probes prior to this analysis, only a small target region of the X chromosome 
was evaluated with this analysis. A whole X chromosome survey was suggested using 
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the 39,XM and 39,XP model mice. While MNase-Seq generates quality data, only 
nucleosome positioning information can be analyzed from the resulting data. A newer 
technique, Assay for Transposase-Accessible Chromatin using sequencing (ATAC-Seq) 
allows for nucleosome positioning data, and also open chromatin and DNA footprint 
analysis132. For this reason, ATAC-Seq was chosen for the survey of the X chromosome 
and will be discussed in the following section. 
Open Chromatin and Nucleosome Occupancy 
 
The method of ATAC-Seq utilizes regions of open chromatin and the binding 
affinity of transposases to sequence all openly accessible regions of chromatin131. 
Utilizing this sequencing technique, a profile of open chromatin can be created to 
examine all regions that are accessible by external machinery for processes including 
DNA replication or transcription. This process can also be used to create a nucleosome 
positioning profile as DNA that is bound to a histone octamer is not openly accessible 
and these regions can be assessed with bioinformatic tools by looking for size specific 
regions where dyads and triads exist due to this inaccessibility. Thus, this data can be 
used to both map open genomic sequence along with nucleosome positioning. Each 
library consists of 50,000 nuclei from frozen M. musculus neocortex tissue and 500 D. 
melanogaster nuclei as a spike-in control. These nuclei are extracted following the 
Omni-ATAC-Seq protocol from the Chang lab133 that improved upon the previous 
ATAC-Seq protocol from the Buenrostro lab134 eliminating the large portion of 
mitochondrial DNA captured and sequenced in the original protocol. Nuclei were 
isolated using an iodixanol gradient solution to eliminate all other cellular components. 
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As depicted in Figure 12, Illumina Nextera transposase is pre-loaded with 
adapter recognition sequences that attach to DNA when incubated at 37°C and allow for 
open chromatin to be amplified with barcoding and indexing primers for Illumina 
sequencing136. Amplification cycles were determined by a Real-Time PCR followed by 
library quantification using the KAPA Illumina Library Kit. Finally, a Qbit quantification 
was conducted to analyze the concentration of the libraries being pooled for loading 
onto the Illumina NextSeq. 
 
 
 
 
Figure 12: ATAC-Seq Protocol 
Transposase (Tn5 transposome - Nextera) ligate Illumina adapters to regions of open 
chromatin for downstream amplification. JD Buenrostro et al, Nature Methods, 2013. 
 
 
 
For nucleosome positioning assays with ATAC-Seq, it is suggested to sequence 
approximately fifty million reads per sample137. And for DNA footprint analysis it is 
suggested to sequence approximately two hundred million reads per sample137. The 
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Illumina NextSeq High Output sequencing kit produces approximately eight hundred 
million reads per run. ATAC-Seq was performed on two 39,XM mice and two 39,XP mice 
giving approximately two hundred million reads for each sample individually allowing for 
DNA footprint analysis to be completed. The Illumina NextSeq 2x75 paired end 75 bp 
sequencing kit was used for samples XM291, XM294, XP1044 and XP1053 and 
sequences were aligned using Bowtie2 according to the ATAC analysis pipeline 
described by the Kundaje lab at Stanford University135. 
 
Table 1 
 
 39,XM 39,XP 
Mapping quality > q30 (out of total) 84.70% 77.80% 
Mitochondrial reads (out of total) 1.10% 0.80% 
Final reads (after all filters) 78.60% 73.00% 
 
 
Paired-end sequencing reads were mapped using Bowtie2 to the mm10 genome 
generating a BAM output. Mapping quality can be seen in Table 1. An overall profile of 
open chromatin domains was viewed with IGV in Figure 13. 39,XM reads were 
normalized to two hundred million to match the amount of reads from 39,XP sequences 
before analysis to avoid mapping bias. Regions of differential open chromatin were 
identified in Xlr3b between 39,XM and 39,XP upstream of the Int3/Ex4 boundary as seen 
in Figure 13. Some differences are noted in the non-imprinted paralogs of Xlr3 and Xlr4 
genes (Figure 14), however, the most substantial differences observed were in the 
imprinted paralogs at the Xlr3/4 locus. Also analyzed were X-linked biallelically 
expressed genes Ddx3x, Sox3, and the imprinted autosomal gene H19, see Figure 15. 
Overall open chromatin profiles appear to be consistent, including H19 due to both 
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parental alleles being present. While some differences exist in the non-imprinted and 
biallelically expressed genes, the data does show a greater difference between the 
imprinted genes, comparatively. 
 
 
Figure 13: ATAC-Seq Profile of the Xlr3 Paralogs 
Open chromatin tracks viewed with IGV. Open chromatin mapping of Xlr3a, Xlr3b, Xlr3c. 
Open chromatin domain differences highlighted by green boxes. 39,XM (Red) and 39,XP 
(Blue) BAM files displaying open chromatin mapping by ATAC-Seq analysis pipeline. 
Quantifiable differences of open chromatin observed in the imprinted gene body to be 
investigated further with DNA footprint analysis. Substantial difference noted at the 5’ end of 
Xlr3b compared to the non-imprinted paralogs. Differential sequencing reads between alleles 
for further analysis. 
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Figure 14: ATAC-Seq Profile of the Xlr4 Paralogs 
Open chromatin tracks viewed with IGV. Open chromatin mapping of Xlr4a, Xlr4b, Xlr4c. 
Open chromatin domain differences highlighted by green boxes. 39,XM (Red) and 39,XP 
(Blue) BAM files displaying open chromatin mapping by ATAC-Seq analysis pipeline. 
Quantifiable differences of open chromatin observed in the imprinted gene body to be 
investigated further with DNA footprint analysis. Differential sequencing reads between 
alleles for further analysis. 
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Figure 15: ATAC-Seq Profile of Ddx3x, Sox3, and H19 
Open chromatin tracks viewed with IGV. Open chromatin mapping of Ddx3x, Sox3, H19. 
Open chromatin domain differences highlighted by green boxes. 39,XM (Red) and 39,XP 
(Blue) BAM files displaying open chromatin mapping by ATAC-Seq analysis pipeline. Ddx3x 
and Sox3 are biallelically expressed genes at different loci on the X chromosome. Overall 
profiles of these genes are similar with few if any quantifiable differences. H19 is located on 
mouse chromosome 7 and is part of the Igf2/H19 imprinting cluster. Included in analysis to 
view open chromatin domains on autosomal locus. Both maternal and paternal alleles are 
represented in the data for H19. 
 
 
 
 
ATAC-Seq quality metrics were determined using the ATAC-Seq/DNase-Seq 
data analysis pipeline developed by the Kundaje laboratory and open sourced from 
GitHub136. Illumina Fastq files were normalized to two hundred million reads for DNA 
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footprint analysis. Quality metric outputs displayed in Figures S4&S5. Figures S4&S5 A) 
depicts an enrichment plot of ATAC-Seq reads relative to a normalized representative 
sample of Transcription Start Sites (TSS’s) while (Figure S4&S5 B) represents an 
aggregate of all enrichment of ATAC-Seq reads across all TSS’s in the genome. Overall 
read fragment length was observed predominantly below ~150 bp correlating to 
nucleosome free regions of open DNA (Figure S4&S5 C). This is important for ATAC- 
Seq data analysis to determine accurate capture of open chromatin regions versus 
nucleosome bound DNA regions. Sequences obtained from this protocol for both 39,XM 
and 39,XP samples passed quality metrics for ENCODE library complexity statistics and 
were determined to be high quality reads for nucleosome positioning and DNA footprint 
analysis, see Table 2. 
 
Table 2 
39,XM # Reads % of Total 
Fraction of reads in universal DHS regions 79,379,373 50.6 
Fraction of reads in blacklist regions 116,773 0.1 
Fraction of reads in promoter regions 20,518,428 13.1 
Fraction of reads in enhancer regions 58,903,814 37.6 
Fraction of reads in called peak regions 37,307,828 23.8 
39,XP   
Fraction of reads in universal DHS regions 60,755,132 46.5 
Fraction of reads in blacklist regions 103,276 0.1 
Fraction of reads in promoter regions 13,573,697 10.4 
Fraction of reads in enhancer regions 47,153,034 36.1 
Fraction of reads in called peak regions 23,788,702 18.2 
 
Nucleosome occupancy is also able to be calculated using ATAC-Seq data using 
open chromatin states as a baseline to detect nucleosome protected regions of DNA 
(Omni-ATAC)133. A python package, NucleoATAC, developed by the Greenleaf lab at 
Stanford University for the purpose of identifying nucleosome occupancy and 
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positioning from ATAC-Seq data sets was used on Illumina Next-Seq sequencing data 
files137. Sequencing files were aligned as previously described with Bowtie2 to the 
mm10 genome. The pipeline configures ATAC-Seq bam alignment files of open 
chromatin and analyzes nucleosome protected regions of DNA elucidating nucleosome 
positioning with a resulting bedgraph output file138. Output bedgraph files were sorted 
with bedtools and then converted to a binary tiled data (.tdf) file for improved IGV 
performance and processing due to the large size of the files. Nucleosome positioning 
results can be seen in Figure 16 and 17. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Nucleosome Occupancy ATAC-Seq 
ATAC-Seq Data analysis with NucleoATAC reveals nucleosome positioning differences 
between 39,XM and 39,XP mouse neonate brain samples at Xlr3b region (A). NucleoATAC 
pipeline used to analyze normalized sequencing data followed by visualization in IGV. 
Overall profile of biallelically expressed F8a (B). Green boxes indicate regions of differential 
nucleosome predicted on the paternal allele of Xlr3b by NucleoATAC pipeline. Slight 
difference at the 3’ end of the gene F8a noted in yellow. 
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Figure 17: ATAC Nucleosome Profile of Biallelically Expressed Genes 
A closer look at two biallelically expressed genes at the XA7.2 region. As seen in the 
previous image, F8a (A.) displays some level of nucleosome differences in the gene 
body. However, at the promoter and 5’ end of the gene, the profiles are almost identical. 
Spin2d (B.) displays only a slight difference of nucleosome positioning at the 5’ end. 
While there is a slight difference it can be seen that some level of nucleosomes do exist 
around the promoter region of Spin2d. 
 
 
 
 
 
Figures 16 and 17 depict the output data from the NucleoATAC pipeline and 
differential nucleosome occupancy was observed between the maternal and paternal 
allele of Xlr3b in normalized data. NucleoATAC utilizes the script pyatac to calculate 
sequence bias and eliminate reads that are not statistically significant nucleosome 
regions139. 39,XP was observed to contain nucleosome peaks where there were none 
on the maternal allele. Particularly, these peaks highlighted in green are positioned 
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proximal to the int3/ex4 boundary. Previously Dr. Sohaib Qureshi had identified a 
potential stalling event of RNA Pol II at this region of Xlr3b. Nucleosomes arranged in 
specific locations in a transcript could inhibit proper active elongation of RNA Pol II thus 
disrupting completion of transcription. This model could explain the previous findings by 
former lab members where transcription initiation is seen to begin, but by intron 7, the 
transcript of the paternal allele is no longer present. Similar differences were seen in 
Xlr4b/4c however, it was not as drastic as Xlr3b. Also of note, Xlr3a and Xlr3c do not 
share this same nucleosome occupancy difference between the maternal and paternal 
allele. This appears to be an imprinted cluster paternal allele specific effect at the Xlr3/4 
locus. The nucleosome positioning maps generated by both MNase-Seq and ATAC-Seq 
displayed regions around the intron3/exon4 boundary and exon 7 enriched on the 
paternal allele. This can be seen in Figure 11 highlighted in green boxes from the diffR 
analysis and also in Figure 16 (A). Another similar region in Xlr3b across the studies is 
intron 1, where there is nucleosomal enrichment identified on the maternal allele. 
Overall, ATAC-seq not only gives a more robust view of nucleosome positioning, open 
chromatin domains, and DNA footprint analysis, it also produced a sufficient number of 
reads to allow for unique mapping. This allows for paralog specificity for the region and 
a more in depth view of Xlr3/4 imprinted cluster. 
Generally, biallelically expressed genes in the region display less dynamic 
nucleosome occupancy across the gene body although it is noted that there are still 
some differences (Figure 17). In the case of F8a it has previously been postulated by 
members of the lab that differences within the gene such as CTCF binding and a DMR 
very well could aide in the imprinting mechanism of the Xlr cluster. The differences seen 
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in nucleosome occupancy of F8a could very well be involved in this mechanism allowing 
or restricting access of transcription factor binding proteins or potentially, insulator 
proteins such as CTCF. Spin2d, the biallelically expressed gene upstream on the X 
chromosome has an almost identical nucleosome positioning profile between the 
maternal and paternal allele. Only a slight difference is observed at the very beginning 
of the gene body. Below in Figure 18, a survey of other regions of the X chromosome 
are depicted starting with the imprinted region of Xist and Tsix and surrounding genes. 
Several nucleosome occupancy differences are noted between the maternal and 
paternal allele. Secondly in Figure 18, Tktl1 displays major differences in nucleosome 
occupancy between the paternal alleles. There has been a long standing debate in lab 
whether Tktl1 is in fact imprinted, and this data could potentially be a novel discovery in 
its imprinting status. The pattern of large nucleosome deserts in one parental allele has 
remained consistent across several X chromosome imprinted genes (Figure 18). Finally, 
a region of biallelically expressed genes is examined. Subtle differences are noted, but 
the presence of large nucleosome deserts are noticeably absent. Five imprinted genes, 
Xlr3b, Xlr4b, Xlr4c, Xist, and Tsix all have displayed these nucleosome differences 
between parental alleles. 
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Figure 18: Survey of Nucleosome Occupancy in Regions of the X Chromosome 
Nucleosome occupancy maps generated by ATAC-Seq reads and the NucleoATAC 
analysis pipeline for (A.) Xist/Tsix, (B.) Tktl1, Flna, Tex28, (C.) Stk26, Frmd7, Rap2c, 
MbnI3 and Hs6st2. Nucleosome occupancy differences noted in blue boxes reflect 
differences between the maternal and paternal alleles. Nucleosome deserts noted in 
imprinted genes while absent on biallelically expressed genes. All nucleosome 
occupancy maps generated with the pipeline with a 95% confidence and normalized 
by sequence count. 
 
 
ATAC-Seq DNA Footprint Analysis 
 
Transcription factor binding motifs are interspersed across the entirety of the 
mammalian genome allowing for proper binding of regulatory proteins to interact with 
the chromatin and drive or inhibit different stages of transcription140. The ENCODE 
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project compiled a database of sequence specific transcription factors (TFSS’s) via 
ChIP-Seq and identified strong DNA binding motifs over a large number of cell types 
and model organisms141,142,143. ATAC-Seq identifies open chromatin regions of the 
genome not bound by nucleosomes which are freely available to bind to regulatory 
proteins. In this way, ATAC-Seq reads enable an investigation of regions for DNA 
binding protein motif sequences across the entire genome. This can also be achieved 
by DNase-Seq, however, recently researchers have begun utilizing ATAC-Seq data to 
conduct DNA footprint analysis134. 
The MEME suite is designed to identify DNA binding protein motifs from 
sequencing data across thirteen different tools. This bioinformatics tool searches 
genome sequence files for known protein binding consensus sequences and scores 
them according to an e-value144. The e-value is used to eliminate background noise 
from the data by determining the number of hits that can be expected by chance when 
searching a database of a given size. Essentially, the value decreases exponentially as 
the score of a match increases. The lower the e-value, the less likely the scored motif 
would occur by chance in the genome. 
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Table 3. 
 
Xlr3b 
39,XM Motif e-Value 39,XP Motif e-Value 
 HXB8 1.20E-81  STAT1 1.20E-119 
FOXI1 2.10E-10 IRF3 1.70E-102 
ZN322 1.60E-09 NR2E3 9.90E-83 
MTF1 2.40E-09 HNF4A 2.00E-04 
DDIT3 4.00E-08 STF1 7.90E-04 
NRF1 1.50E-07 FOXI1 2.60E-03 
SMAD4 1.60E-06 VDR 2.60E-03 
P63 2.40E-06 SP7 9.70E-03 
THA11 1.60E-04 RARA 1.90E-02 
DBP 2.00E-04 BACH1 2.60E-02 
STA5A 2.40E-04 TGIF1 2.80E-02 
CUX2 1.90E-03 ZKSC1 3.30E-02 
SMCA5 2.00E-03  
CRX 3.60E-03 
ZFP42 9.10E-03 
HXA1 2.10E-02 
NKX28 2.80E-02 
F8a 
39,XM Motif e-Value 39,XP Motif e-Value 
 ZN281 6.2E-456  ZN281 5.2E-644 
TGIF1 2.1E-421 INSM1 9.5E-472 
SP3 1.1E-323 MYF6 1.0E-377 
BHA15 1.0E-214 KLF4 1.2E-208 
SP2 4.8E-198 SP3 2.5E-198 
RORA 5.7E-180 SP2 2.5E198 
ZFX 2.5E-139 ZN335 7.3E-110 
HIC1 8.4E-128 NR1D1 1.1E-104 
KLF6 1.8E-103 LEF1 1.4E-77 
LEF1 8.4E-103 ZIC3 6.4E-50 
INSM1 2.9E-90 EGR1 2.5E-43 
MYF6 8.7E-81 MYOD1 3.0E-36 
ZNF335 4.0E-69  
ZIC3 2.1E-67 
 
Table 3: Meme-ChIP Output for Xlr3b and F8a 
Motif binding site analysis output from Meme-ChIP suite. Open chromatin reads analyzed for 
Transcription Factor (TF) binding motifs. Highlighted motifs indicate binding sites similar 
between the maternal allele (left) and paternal allele (right). Xlr3b observed with only one 
similar motif between parental alleles. Biallelically expressed gene F8a observed with eight 
similar motifs. 
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Table 3 shows the results of the MEME suite analysis for reads mapped to Xlr3b 
and the bialllelically expressed gene F8a from the ATAC-Seq analysis. Although 
different parental alleles should be sequence similar, a drastic difference of DNA protein 
binding motifs have been identified. Signal transducer and activator of transcription 1 
(STAT1)145 and Interferon regulatory factor 3 (IRF3)146 are implicated in the immune 
response but have not yet been associated with imprinted genes in the literature. 
Nuclear receptor subfamily 2, group E, member 3 (Nr2e3) is a known TF binding protein 
that interacts with several other proteins to regulate transcription147,148,149,150. Two 
known interactions are with Nuclear receptor co-repressor 1/2 (Ncor1151 & Ncor2152,153) 
which have been shown to suppress transcription in mouse. Particularly, these TF 
proteins are known to repress transcription by chromatin condensation151,152,153. 
 
Figure 19: Protein Interaction Map of Nr2e3 
Graphical protein interaction map of TF binding protein Nr2e3 found on the paternal 
allele of Xlr3b in mouse. Map shows known interactions of Nr2e3 with other TF proteins 
that influence transcription. Courtesy of String Consortium. 
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IRF3 has been shown to bind to the TF E1A binding protein p300 (Ep300) which 
functions as a histone acetyltransferase and regulates transcription via chromatin 
remodeling154. Contrary to the transcriptionally silent state of the paternal allele of Xlr3b, 
Ep300 acetylates all four core histones in nucleosomes that gives an epigenetic tag for 
transcriptional activation. It is thought that acetylation of histone H3 at Lysine-122 
(H2K122ac) stimulates transcription by possibly promoting nucleosome instability155. 
This instability of nucleosomes could account for the dynamic differences between the 
maternal and paternal alleles of the imprinted locus. The presence of an Nr2e3 binding 
motif on the paternally silenced allele could begin to explain how this allele is 
preferentially silenced compared to the expressed maternal allele. However, the 
presence of a binding consensus sequence does not necessarily correlate to physical 
binding of the protein in vivo. 
 
Conclusions 
 
Although Dr. Foley identified a potential region of differential methylation located 
within the F8a gene between Xlr4b and Xlr4c the role of this DMR has yet to be 
classified. The previous findings of no differential DNA methylation at the Xlr imprinted 
cluster in conjunction with Dr. Kasowitz’s primary transcript data and Dr. Qureshi’s RNA 
Pol II stalling event strongly suggested a co-transcriptional process regulating the 
genomic imprint at the Xlr3/4 region. However, with Dr. Qureshi’s findings now in 
question, the data provided in this work suggests an independent finding. Differential 
nucleosome positioning could perturb active transcription throughout the paternal allele, 
or perhaps provide a locus for epigenetic marks allowing active transcription on the 
maternal allele yet to be identified. While nucleosome positioning has been shown in 
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organisms to affect active transcription, it has not yet been shown to be a part of an 
imprinting control mechanism in mammals. RNA Pol II stalling events are not unusual 
and recently it has been shown that pausing proximal to the genes promotor occurs 
early during active transcription but typically at the 5’ region of the gene156. This pausing 
is thought to be involved with the process of the transcription machinery adding a 5’ cap 
important for translation and RNA stability157. This specific pause however, would not 
account for the observation by Dr. Qureshi. Nucleosome positioning is not observed to 
be responsible for this stalling mechanism as at the 5’ region of the gene. This would 
suggest that nucleosome positioning is not directly involved in overcoming the stall 
during transcription initiation. In Figure 20, a nucleosome peak can be seen at the 
inton1/exon1 boundary where no peak is detected on the paternal allele. This 
differential nucleosome positioning could be a region of interest to the imprinting 
mechanism as will be discussed later in this section. This maternal specific nucleosome 
peak could allow for specific TF binding proteins to allow active transcription to occur 
solely on the maternal allele. How this nucleosome has been positioned differently to 
the paternal allele is yet unknown. 
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Figure 20: Nucleosome Occupancy ATAC-Seq Xlr3b 5’ 
Analysis of Xlr3b 5’ region nucleosome occupancy by ATAC-Seq. Sparse placement of 
nucleosomes at the 5’ end of the maternal and paternal allele indicative of accessibility for 
transcription initiation of both alleles. Peak noted at the intron1/exon1 boundary. 
 
 
 
The X chromosome alleles are known to share 100% sequence identity and thus 
silencing due to sequence specific stalling or perturbation, which has been observed in 
A+T-rich regions, can be ruled out as an influence on the imprinting control 
mechanism158,159. Overall nucleosome occupancy at the imprinting cluster displays 
differential positioning, seen in Figure 21. Although Dr. Qureshi’s analysis was the 
starting point of these experiments, this data stands alone in observing differences 
between the maternal and paternal X chromosome. 
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Figure 21: Differential Nucleosome Positioning at the Xlr3/4/5 Locus 
NucleoATAC nucleosome peaks visualized by IGV at the XA7.2 region across part of the 
Xlr paralog superfamily containing the imprinted paralogs (A). Boxes indicate regions of 
differentially positioned nucleosomes. Non-imprinted genes do not display distinct 
differences compared to imprinted genes. (B) A zoomed in image of NucleoATAC peaks at 
the imprinted Xlr genes. Distinct differential positioning of nucleosomes present at the 
Int3/Ex4 boundary. 
 
While this differential nucleosome positioning does not by itself establish an X 
chromosome independent imprinting control mechanism, it does provide novel insight to 
the potential role nucleosome occupancy may play in regulating transcription at 
imprinted loci such as Xlr3/4. There were stark differences observed in the DNA TF 
binding motifs identified by the MEME suite from my ATAC-Seq data (Table 3). When 
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comparing binding sites only one (Foxi1)160 is shared between the maternal and 
paternal Xlr3b alleles. This binding motif difference suggests activating and silencing 
transcription factors are able to bind to different parental alleles. What remains to be 
seen is what causes the regions of open chromatin between the alleles to be different. A 
potential nucleosome rearrangement may occur to allow for transcription factor binding 
proteins to effectively access the maternal allele. Conversely, the paternal allele could 
undergo a nucleosome rearrangement to ensure the silencing of that allele. 
 
 
 
 
 
Figure 22: DNA TF Meme Suite Output 
Depicted are the top three motifs identified by MEME analysis for the Xlr3b gene 
sequence for (A) 39,XM and (B) 39,XP. Of the top 13 hits, only one shared motif was 
identified (Foxi1). Consensus sequences e-value for each were above 1.60E-09 
indicating a high confidence. 
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The predominant difference between the two alleles is the parent of origin of the 
X chromosome suggests an epigenetic mechanism independent of DNA methylation 
causing silencing specific to the paternal allele. This is a novel hypothesis for an 
imprinting control mechanism and could be used to identify potential currently 
unidentified imprinted genes on both the mouse and human X chromosome in the future 
by searching the X chromosome for genes with similar regulatory characteristics. Figure 
22 displays a graphical depiction of the consensus sequence for the top three TF 
binding domains identified by the MEME suite analysis program. DNA footprint profiles 
appear to be very different between parental alleles. In fact out of the top 13 motifs, only 
one (Foxi1) was similar. 
 
Figure 23: DNA Footprint Analysis of Xlr3 Paralogs 
DNA Footprint of 39,XM (Red) and 39,XP (Blue) for the genes Xlr3a, Xlr3b, and Xlr3c. 
Data produced by the python script RGT-HINT. DNA footprints depict model active 
binding sites at the TSS of Xlr3a and Xlr3b on the maternal allele. No active binding sites 
are detected on any paternal allele. Xlr3c is absent of any predicted active binding 
domains. Previously predicted TF binding sites mapped with the Sequence Manipulation 
Suite. 
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DNA footprint analysis was accomplished using the RGT suite, and specifically 
the Hmm-based IdeNtification of Transcription Factor Footprints (HINT) script. This suite 
allows for MACS2 peaks to be manipulated to generate detected regions of increased 
and decreased histone modification and ATAC signals. It was originally adapted from a 
suite tailored for DNase-seq experiments to be used with ATAC-Seq data. This pipeline 
uses a bias-corrected signal before normalization steps making it a preferred method for 
DNase/ATAC-Seq analysis. Seen in Figure 23 predicted active binding sites proximal to 
the TSS can be seen on the maternal allele for Xlr3a and Xlr3b however no active 
binding sites are predicted on the maternal allele for Xlr3c. Xlr3a does depict active 
binding sites on the paternal allele, however not at the TSS. Xlr3b does not contain any 
predicted active sites on the paternal allele. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: DNA Footprint Analysis of X Chromosome Genes 
DNA Footprint of 39,XM (Red) and 39,XP (Blue) for the genes Ddx3x, Sox3, and Rhox5. 
Data produced by the python script RGT-HINT. DNA footprints depict active binding sites 
at the TSS of Ddx3x, Sox3, and Rhox5 on both parental alleles. A similar profile is seen 
across Ddx3x and Sox3, however, at the 3’ end of the maternal allele of Rhox5 there are 
predicted sites and none on the paternal allele. 
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As seen in Figure 24, biallelically expressed genes Ddx3x and Sox3 display 
virtually identical DNA Footprint profiles. Rhox5, a known imprinted gene, shares a 
similar 5’ end between parental alleles. However, the 3’ region displays peaks only on 
the maternal allele. The similarity observed between parental alleles of biallelically 
expressed genes and the differences observed between known imprinted genes 
suggests a potential role of predicted active binding sites at the loci. Further analysis will 
need to be conducted to elucidate the role of these binding sites and the transcriptional 
activity at the Xlr3/4 locus. 
Combining the data from the MNase-Seq assay for maternal and paternal 
enrichment with the ATAC-Seq nucleosome positioning prediction shows consistency 
between predicted loci, see Figure 25. This overlap between the two assays provides 
insight into differentially positioned nucleosomes on the parental alleles. Several loci as 
seen in Figure 25 identified originally by MNase-Seq, displayed maternal enrichment 
and paternal depletion later in the ATAC-Seq assay. These differentially positioned 
nucleosomes could influence the overall transcriptional activity at the imprinted Xlr 
locus. 
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Figure 25: MNase-Seq Enrichment Comparison to ATAC-Seq Nucleosome Positioning 
Nucleosome MNase enrichment of maternal nucleosomes (bottom – red) align with predicted 
nucleosomes on the maternal allele from NucleoATAC output. Similarly, paternal enrichment 
of nucleosomes (bottom – blue) align with predicted nucleosomes from NucleoATAC. 
 
A recent publication by Shioda et al. examining a mouse knockout of the 
chromatin remodeler, Atrx, identified a CpG island in Xlr3b at the intron1/exon1 
boundary that appears to be differentially methylated according to the presence or 
absence of Atrx161. This CpG island corresponds to the region investigated by B. 
Carone that was found to be equally methylated on both parental alleles (Figure 6). This 
region was also predicted to form the non-canonical DNA secondary structure know as 
a G-quadruplex by the QGRS Mapper162. The knockout of Atrx in hippocampus of adult 
male mice upregulated Xlr3b expression161. The group reasoned that Atrx is recruited to 
the G-quadruplex region, and in turn, recruits DNA methyltransferases (Dnmts) to 
establish a DMR regulating gene expression161,163,164,165. It has previously been reported 
that ATRX acts within a histone chaperone complex, along with DAXX to deposit 
histone variant H3.3 in heterochromatic regions enriched for H3K9me3166. In Figure 26, 
I identified differential nucleosome occupancy on the maternal allele of Xlr3b aligning to 
the same region of this reported G-quadruplex from the Shioda group161. H3.3 has been 
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previously shown to be associated with active gene transcription by opening otherwise 
compact chromatin regions167. 
 
 
 
Figure 26: G-Quadruplex Alignment with Nucleosome Occupancy 
Nucleosome occupancy at Xlr3b (A.) and Xlr4b (B.) in relation to the presence of predicted 
G-quadruplexes. Both imprinted genes display differential nucleosome occupancy in the 5’ 
region of the gene body correlating to the location of a high scoring G-quadruplex prediction. 
These regions are believed to interact with ATRX acting as a chromatin remodeler by means 
of a histone chaperone complex. 
 
 
As seen in Figure 26, differential nucleosome occupancy on the maternal allele 
of the two sense strand imprinted genes in the Xlr locus correspond to predicted G- 
quadruplex regions. These nucleosomes have the potential to be modified by ATRX 
with the deposition of H3.3 causing the maternal allele to be actively transcribed while 
the paternal allele would remain silent. An imprinting mechanism involving differential 
66  
nucleosome positioning and ATRX deposition of H3.3 has not yet been identified and 
would be a novel discovery. This mechanism would explain the actively transcribed 
maternal allele compared to the transcriptionally silent paternal allele. 
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Chapter 4: The Transketolase-Like 1 Gene in Neurodevelopment 
 
Discovery of Tktl1 Imprinted Expression in Mouse 
 
Since imprinted genes often occur in large clusters, former O’Neill lab member 
 
A.M. Nesbitt tested genes for PSGE in a 1 Megabase region surrounding the Xlr3/4/5 
genes. PSGE of autosomal imprinted genes is generally strongest during embryonic 
stages of mouse development168. For this reason, Dr. Nesbitt performed her screen via 
qRT-PCR using embryonic liver, brain, and placenta from 39,Xm and 39,Xp mice. She 
first detected maternal dominant expression of Transketolase-like 1 (Tktl1) in embryonic 
stage 14.5 (E14.5) liver. Dr. Nesbitt then assayed for imprinted expression of Tktl1 in P0 
brain sub-regions due to the link of imprinted genes and neurocognitive ability. A five- 
 
 
 
Figure 27: Dr. Nesbitt Real-Time PCR results of Tktl1 Expression 
A statistically significant difference was observed between the different genotypes in all 
tissues analyzed (p<0.05). Error bars indicate a ninety-five percent confidence interval. 
Adapted from Dr. Addie Mae Nesbitt. 
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fold higher expression was observed in 39,XM neocortex compared to 39,XP along with 
an eight-fold difference in olfactory bulb, and two-fold difference in cerebellum (Figure 
27). The allelic dominance in expression indicates that Tktl1 is regulated by what is 
termed a “partial” imprint. 
In conjunction with mouse studies, Dr. Nesbitt assayed allele-specific expression 
of TKTL1 in a 46,XX 19 week human fetal brain sample (Figure 28). She again 
observed sub-region-specific partial imprinting: noting, for example, a five-fold allelic 
dominance in thalamus, and two-fold allelic dominance in frontal cortex. However, the 
lack of parental DNA matching this fetal brain sample made it impossible to determine 
which parental allele was the more highly expressed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: 19 Week Fetal Human Brain TKTL1 Expression 
TKTL1 expression levels in human fetal brain tissue sub regions using c.-44dupT allele 
imprinting primer set. Thalamus displays greatest fold difference in 19w Human brain 
samples. This data suggested at the time TKTL1 may in fact be imprinted in human 
brain as well as mouse brain tissue. This data propelled experiments looking at the link 
between TKTL1 and ASD. Adapted from Dr. Addie Mae Nesbitt. *Only one fetal brain 
sample was ever obtained for analysis. 
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TKTL1 Expression in Human Brain Sub-regions 
 
Skuse et al.2 showed that Turner Syndrome (TS) females who inherited the 
maternal X chromosome, 45,XM show lower 
social cognitive ability than TS females who 
inherited the paternal X chromosome, 
45,XP, implicating X-linked imprinted genes 
in neurodevelopment of social and 
cognitive ability. Furthermore, Skuse 
showed TS females that inherited the 
paternal X chromosome displayed similar 
social cognitive ability to 46,XY males 
and control 46,XX females demonstrated 
the highest level of social cognitive 
ability2. TKTL1 is a potential candidate 
Figure 29. Non-Oxidative Phase of the 
Pentose Phosphate Pathway: Function of 
Transketolase in converting Ribulose 5- 
phosphate and production of NADPH. p. 
863 of Biochemistry, by Voet & Voet, 3rd 
Edition. 
gene involved in poor social cognitive ability due to the role it may play in the production 
of NADPH and ribulose-5-phosphate in the Pentose Phosphate Pathway (PPP)169. 
Transketolase is the rate limiting step in the non-oxidative phase of the PPP (Figure 29) 
responsible for the reversible conversion of ribose-5-phosphate to glucose-6-phosphate 
which results in the reduction of NADP+ to NADPH. NADPH is essential for the 
reduction of glutathione which in turn is responsible for reducing hydrogen peroxide 
(H2O2)170,171. Reducing H2O2 results in a decrease of oxidative stress and 
neurodegeneration170,171. 
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Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was used to 
assess the relative abundance of TKTL1 transcripts present in neurotypical and ASD 
human brain sub-region tissue samples. The goal of this analysis was to determine if 
there is a correlation between the level of TKTL1 gene expression, or its imprinting 
status in sub-regions of the brain and diagnosis of ASD. Post-mortem frozen brain 
tissue samples were obtained from the NIH Neurobiobank and RNA was extracted with 
Qiagen RNeasy extraction kits. Sample purity and concentration was quantified by 
Nanodrop analysis and samples were normalized to 1000 ng RNA per cDNA synthesis 
reaction with cDNA Superscript. Samples were analyzed on the BioRad Real Time 
Thermocycler using exonic primer pairs designed as depicted in Figure 30. 
 
 
Figure 30. Primer design for qRT-PCR products in H. sapiens TKTL1 
TKTL1-1 (1) forward designed in 5’ UTR/Exon 1, reverse located in Exon 3. TKTL1-3 (3) 
designed in Exon 9, reverse located in Exon 11. TKTL1-1 located in Thiamine Pyrophosphate 
(TPP) domain. TKTL1-3 located in Transketolase C-terminal domain. 
 
 
Cycle thresholds from qRT-PCR were imported into Microsoft Excel and fold 
change comparing autistic and control samples were calculated using ΔΔC(T) 
method172. β-Actin and GAPDH mRNA were used as a reference housekeeping gene 
for normalization. A statistically significant difference in relative gene expression was 
observed between parietal brain tissues from females diagnosed with ASD compared to 
neurotypical females (Figure 31). However, no statistically significant difference was 
observed in female occipital, male occipital or male parietal tissue. With the high 
prevalence of ASD diagnosed in males, approximately 5:1 ratio compared to females1, 
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we had expected to find high levels of TKTL1 expression in male brain tissue. A 
possible explanation, if TKTL1 over-expression is indeed related to the development of 
ASD, a threshold effect may occur. Females having one inactivated X chromosome may 
escape harmful effects. Whereas in males, having only one X chromosome may be 
more vulnerable to these harmful effects. If a female inherits a mutated copy of a gene 
on the X chromosome, ~50% of cells will express the aberrant allele. A mutation may 
not present as detrimental if it is expressed only in a sub-population of cells. In brain for 
instance, if a specific region is affected with an inherited mutation, another region will 
not be. When the mutation is located in a region necessitating the proper allele, 
detrimental effects will produce a phenotype. Since X inactivation occurs randomly, 
there is a protective effect to silencing a potentially deleterious allele. With this in mind it 
is possible this statistically significant difference in TKTL1 expression could be indicative 
of the potential development in females with ASD. 
A significant difference in TKTL1 expression levels between neurotypical and 
ASD samples would support the hypothesis of a role for TKTL1 in the 
neurodevelopmental defects underlying ASD. Incorrect regulation of TKTL1 could result 
in increased amounts of ROS causing lipid bilayer proliferation in neurological cell 
membranes. No significant difference between TKTL1 expression levels may indicate 
an earlier critical window for TKTL1 in the developing brain. Many genes and 
transcription factors have been shown to be necessary during certain developmental 
time points in fetal brain development156. During embryogenesis TKTL1 regulation may 
be more important for proper neurological development. Quantitative Real Time PCR 
72  
** 
analysis shows increased expression between neurotypical and autistic female brain 
samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: Relative TKTL1 expression in control vs. autistic females 
Relative expression of TKTL1 using qRT-PCR in female brain. Data transformed using Log10 for 
normal sample distribution. All relative expression normalized to β-Actin. A. TKTL1-1 primer set 
designed to 5’ end of gene from Exon 1 to Exon 3. Three of four Autistic samples had higher 
relative expression compared to neurotypical control samples, however they are not statistically 
significant. Levene’s Test: F=8.063, df=6, p=0.03. T-Test: df=6, p=0.156. B. TKTL1-1 primer set 
designed to 3’ end of gene from Exon 9 to Exon 11. All Autistic samples had higher relative 
expression compared to neurotypical samples. Levene’s Test: F=1.628, df1=6, p=0.249. T- 
Test: df:6, p=0.004. 
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TKTL1 Imprinting Status in Human Brain Sub-regions 
 
The conventional experiment to conclusively determine genomic imprinting is the 
detection of monoallelic expression of a SNP in a cDNA sample in an individual 
heterozygous for the SNP in their genomic DNA. This method displays the suppression 
of one allele in the mRNA production pathway and thus, confirms that genomic 
imprinting is occurring at the locus. To examine the imprinting status of neurotypical and 
ASD human brain sub-regions, RNA was extracted with the RNeasy kit from Qiagen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Sequencing Analysis of TKTL1 SNP Present in Human Brain Sub-regions 
A comparison of neurotypical female brain samples and ASD brain sub-regions for 
monoallelic and biallelic expression. Neurotypical females appear to have imprinted 
expression of TKTL1 in parietal tissue while ASD females appear to lose that imprinted 
expression in the same tissue. 
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and treated with Qscript mastermix (Quanta) to create cDNA for sequencing analysis on 
the Sanger 3130 in the Center for Genome Innovation (CGI). Sequences were viewed 
with Finch TV sequence viewer software and analyzed for the presence of SNPs in the 
genomic DNA. SNPs were identified and compared to the cDNA sequencing results to 
determine whether biallelic or monoallelic expression of the SNP in mRNA could be 
observed. The results determined that in neurotypical female parietal brain, monoallelic 
expression could be identified signifying genomic imprinting in this sub-region. In 
contrast, female occipital brain displayed biallelic expression of the SNP across all 
samples in neurotypical and ASD brain. Interestingly, ASD female parietal brain as 
shown in Figure 32 displayed a loss of parietal region-specific imprinting compared to 
their neurotypical counterparts. 
Conclusions 
 
Significant differences exist between neurotypical female brain and ASD female 
brain in a subregion specific manner. The combination of the data showing a statistically 
significant increase in relative expression of TKTL1 transcripts in ASD female parietal 
brain and the loss of imprinting status points to a potential correlation between the loss 
of the imprint and the development of this neurodevelopmental disorder. Moreover, it 
supports the hypothesis set out by Skuse et al. indicating imprinted genes on the X 
chromosome influence the cognitive ability of individuals2. To date, no confirmed 
imprinted genes have been identified on the human X chromosome, however, my work 
along with the work previously done by Dr. Addie Mae Nesbitt has provided preliminary 
evidence of Transketolase-like 1 imprinting status not just on the mouse X 
chromosome, but also on the human X. 
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Several explanations could suggest why TKTL1 is not observed to be over 
expressed in ASD male brain. First, a high post-mortem interval (PMI) is observed in 
several brain samples, as seen in Figure S6. RNA degradation due to this high PMI 
could account for skewed results in expression analysis. Excluding samples 1638 and 
1349 as PMI outliers, the average difference between neurotypical and ASD males PMI 
is higher than that of females in this study. With this fact, it is possible that RNA 
degradation influenced the results as a source of error for the male brain samples more 
substantially than the females. Also, when acquiring samples from the Neurobiobank, 
there were inconsistencies among the labeled brain sections received, meaning a brain 
subregion may have been incorrectly categorized before shipment. Additionally it is 
worth noting that the cause of death of many of the subjects, asphyxiation related 
causes, could be indicative of increased oxidative stress (Figure S6). Lastly, it is 
possible that TKTL1 is not directly associated with ASD in males, and is female ASD 
specific. Without being able to obtain precise brain sub-region samples from the 
Neurobiobank, increasing the cohort was not possible. While an N=4 is a low cohort of 
samples for statistical significance, these findings do suggest a pattern in female 
parietal brain. 
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Chapter 5: Characterization of the TKTL1 Protein 
 
There is a debate in the literature about the 
function of the protein Tktl1 (or in human TKTL1). 
As stated previously, Coy et al.174 and Schenk et 
al.194 postulate that TKTL1 is the rate limiting 
enzyme in the PPP controlling the production of 
metabolites in the non-oxidative phase. However, 
Meshalkina et al. argues that TKTL1 does not itself 
even function as a canonical transketolase due to 
 
Figure 33: Tkt and Tktl1 
Conservation. Pairwise protein 
alignment of Tkt and Tktl1 in 
mouse. Alignment done with 
EMBOSS Water alignment tool. 
a 38 amino acid residue deletion in the N-terminal region of TKTL1 that encompasses a 
binding site for the essential co-enzyme, thiamine195. It has been shown that Tkt is 
phosphorylated at a threonine at amino acid position 382 (Thr382) by protein kinase B 
(Akt) and that this phosphorylation event is critical for Tkt function196. The 
phosphorylation activation site, Thr382, is conserved between mouse and human Tkt and 
Tktl1 proteins, as shown in Figure 33. This conservation could be a clue to the overall 
function Tktl1 serves in the cell and ultimately the role it may play as a regulating 
enzyme in the PPP. This chapter aims to elucidate the potential interactions of Tktl1 in 
HT-22 mouse hippocampal cells and also in utero electroporation (UTE) transfected 
mice. 
Tktl1 maps approximately 500 kb from the Xlr3/4 cluster in mice and the human 
ortholog TKTL1, is found in the syntenic region of the human X, mapping to Xq28. It is 
not currently known if TKTL1 functions as a transketolase despite encoding for a 
paralog of the autosomal transketolase gene, TKT197. In the PPP, transketolase is a rate 
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limiting step in the reversible non-oxidative portion of the pathway, and it is critical for 
providing the cell with ribose-5-phosphate for nucleotide synthesis and NADPH in 
conditions of oxidative stress189,190. A disruption in NADPH production could result in 
increased levels of free radicals, or reactive oxygen species (ROS). NADPH is required 
to reduce cellular glutathione which in turn converts the ROS peroxide to water. ROS 
are damaging to cells, nerve cells in particular, reacting with the lipid bilayer causing 
lipid peroxidation and cellular death198. Oxidative stress has been investigated as a 
causative factor of cellular degeneration by measuring the relative concentration of 
detoxifying agents such as reduced glutathione along with lipid peroxidation 
byproducts199,200. Incorrect regulation of TKTL1 imprinting in specific brain sub-regions 
may alter transketolase activity, thus altering the ability for neurons to produce an 
appropriate amount of reducing agents leading to increased oxidative damage and 
neurodegeneration201. 
A cell line derived from mouse hippocampus (HT-22) was used due to the 
difficulty to culture and grow primary neuronal cell lines202. HT-22 cells grow effectively 
in culture and can be easily transfected. In these experiments, transfection was 
conducted with the Neon Transfection System from Thermo Fisher Scientific utilizing 
electroporation. This method allows for plasmids and vectors to be transfected through 
the cell membrane by electrical pulse203. A mouse model system to investigate the 
enzyme reaction of the PPP was chosen due to high level of conservation between 
human and mouse systems. Additionally, HT-22 cells serving as a model for human 
cells undergoing oxidative stress and other disorders is well-documented in the 
literature200,201,202. An expression construct developed by Dr. Nesbitt including the full- 
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length coding DNA sequence for human TKTL1 was ligated into a pCAGGS vector (gift 
from the J. LoTurco laboratory). The pCAGGS vector is controlled by a chicken β-actin 
promoter and has been observed to be highly expressed in several cell types205. 
TKTL1 Protein Interactions 
 
Tkt is activated by the phosphorylation of Thr382 by Akt as part of the mammalian 
Target Of Rapamycin (mTOR) pathway to produce sufficient growth factors, 
extracellular nutrients and amino acids to allow proper cell proliferation196. As stated 
above, activated Tkt is an integral and rate limiting enzyme in the non-oxidative phase 
of the PPP187. Due to the conserved Thr382 phosphorylation activation site present in 
TKTL1, I decided to investigate the potential for interactions between the Akt kinase, Tkt 
and TKTL1. The transfected construct contained human TKTL1 cDNA to allow it to be 
distinguished from endogenous mouse Tktl1 in gene expression assays. My working 
hypothesis was that human TKTL1 would work as a regulating factor for the activation 
of endogenous Tkt in the cell. With the conserved Thr382 binding site, TKTL1 could act 
as a competitive inhibitor by providing additional Thr382 sites for activation by Akt, 
decreasing the amount of Tkt phosphorylation events and thus influencing the reversible 
reactions of the non-oxidative phase of the PPP. In this way, aberrant TKTL1 
expression could explain the increased levels of oxidative stress and provide a direct 
link to the over expression of TKTL1 observed in female parietal brain and the 
development of ASD. 
To elucidate the potential for interactions between Akt/Tkt and Akt/hTKTL1 a 
 
pCAGGS-hTKTL1 vector was transfected via electroporation into the HT-22 cell line and 
transfected cells were assayed for expression of endogenous Tkt, hTKTL1 mRNA, and 
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glucose-6-phosphate 1-dehydrogenase (G6pd). G6pd is another gene on the X 
chromosome of the mouse that encodes a protein integral to the PPP. This gene was 
used in expression experiments to demonstrate the transfection of hTKTL1 did not alter 
the expression of other genes involved in the PPP. As is shown in Figure 34, the 
pCAGGS promoter was able to drive hTKTL1 expression to high levels in transfected 
HT-22, while not increasing expression of other genes involved in the PPP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34: qRT-PCR HT-22 Transfected Cell Lines 
qRT-PCR results of pCAGGs-TKTL1 transfection in HT-22 cells. HT-22 control cells depicted 
in blue and transfected +hTKTL1 HT-22 cells depicted in red. No statistical difference 
observed in either Tkt or G6pd expression. Highly significant difference observed between 
control HT-22 cells and +hTKTL1 transfected cells. T-Test ***p=0.00012 for transfected HT- 
22 cells compared to control. All values normalized to β-actin. 
 
 
 
To investigate protein-protein interactions, co-immunoprecipitation (co-IP) assays 
were performed using an antibody to endogenous Akt. A co-IP utilizes an antibody of a 
known protein, in this case Akt, believed to form a strong association with another 
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protein creating a protein/protein complex. Using this antibody for an IP allows for both 
proteins, if strongly bound, to be pulled down together. Instead of blotting for the known 
protein, a second antibody against the potential associated protein is used during the 
western blot, in this case, Tkt and TKTL1 respectively. It is then possible to assess the 
protein/protein interactions of interest188. Protein complexes immunoprecipitated with 
the Akt antibody were separated via polyacrylamide gel-electrophoresis and western 
blotted. Western blots were treated with antibodies to either Tkt or TKTL1. As shown in 
Figure 35, both Tkt and TKTL1 show protein/protein interaction with Akt. A modest but 
significant decrease in interaction of Tkt with Akt in the transfected cell line was 
observed compared with the control HT-22. Biological replicates were analyzed with 
ImageJ for band concentrations and two tail p-value calculated by t-Test for paired two 
sample for means with an alpha of 0.05. TKTL1 is detected interacting with Akt in the 
transfected cell lines and not in the control HT-22 cells. This result suggests that over 
expression of TKTL1 mRNA, and thus increased TKTL1 protein, may interfere with the 
canonical interaction between the two proteins altering the efficiency of Tkt to function in 
the PPP as proposed by my hypothesis. 
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Figure 35: Co-IP of Tkt/Akt and TKTL1/Akt 
Co-immunoprecipitation depicting the interactions between Akt with Tkt (A) and Akt with 
TKTL1 (B). Modest decrease in interaction observed in Tkt, *p=0.015 (A) and a qualitative 
interaction observed with Akt/TKTL1 (B). α-tubulin as loading control, normalized data show 
protein/protein interactions with Akt. Concentrations of protein bands measured with ImageJ. 
Histogram of densitometric quantification of band concentrations ratios to background and 
normalized to loading control (D). 
With the data suggesting that both Tkt and TKTL1 interact with Akt the next step 
was to assess whether the phosphorylation status of Tkt was altered when TKTL1 
mRNA was over expressed. To elucidate this, a protein immunoprecipitation with a 
monoclonal Transketolase antibody (Thermo Fisher) and a polyclonal TKTL1 antibody 
(Thermo Fisher) were used to pull down the protein of interest in an 
immunoprecipitation. Following this, the PVDF membrane was blotted with a phospho- 
threonine antibody to quantify phosphorylation in protein present. My hypothesis was 
that in control HT-22 cells phosphorylation of Tkt would be higher compared to that of 
the transfected cells lines, suggesting hTKTL1 is interfering with phosphorylation of Tkt. 
The interaction of Akt with hTKTL1 would also predict phosphorylation of hTKTL1 in the 
transfected cells lines and little to no phosphorylation in the control HT-22 cells. Any 
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detection of phosphorylation of TKTL1 in control HT-22 cells would likely be background 
endogenous mouse Tktl1 cross reacting with the polyclonal antibody to hTKTL1. 
 
 
 
Figure 36: Tkt and TKTL1 IP for Phosphorylation Analysis 
HT-22 cell lines and hTKTL1 transfected cell lines showing differential protein quantification 
after immunoprecipitation. IP with Tkt antibody and blotted for phospho-threonine (A) 
**p=0.0067. IP with TKTL1 antibody and blotted for phospho-threonine (B) ***p=0.00064. 
Total loading control (C) with α–tubulin primary antibody. After transfection, Tkt 
phosphorylation (activation) is knocked down. TKTL1 phosphorylation is detected in 
transfected cells. Histogram of densitometric quantification of band concentrations ratios to 
background and normalized to loading control (D). Data suggests that the presence of 
constitutively transcribed hTKTL1 in HT22 cells decreases the phosphorylation of 
endogenous Tkt. 
 
 
As seen in Figure 36, phosphorylation is decreased for Tkt in transfected HT-22 
cell lines, concurrent with high expression and high levels of phosphorylation of TKTL1. 
This data support the hypothesis that TKTL1 acts as a competitive inhibitor of Akt 
phosphorylation of Tkt, thereby potentially inhibiting the non-oxidative phase of the PPP. 
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Figure 37: Relative Ratio of Glutathione and NADPH in Cells 
Relative ratio of GSD/GSSH (A) and NADPH (B) in mouse hippocampal cell lines, HT-22, 
transfected with pCAGGS/TKTL1 vector. A statistically significant difference was observed 
between control HT-22 cells and transfected cell lines over expressing TKTL1. Error bars 
indicated a ninety-five percent confidence interval. Assays conducted by Amy Friss. 
 
 
 
Interestingly, over expression of transketolase or transaldolase, both involved in 
the non-oxidative phase of the PPP, has been linked to increased oxidative stress. 
Schenk et al. along with Coy et al. have proposed and shown evidence that one of the 
transketolase enzymes (Tkt or TKTL1) is the rate limiting enzyme in the non-oxidative 
phase of the PPP175,176. Previous work done in the O’Neill lab by Amy Friss showed that 
forced over-expression of TKTL1 in the mouse hippocampal cell lines, HT-22, reduced 
the levels of glutathione and NADPH produced during the non-oxidative phase of the 
PPP, see Figure 37. This reduction of glutathione and NADPH inhibits the neural cells’ 
ability to reduce ROS’s such as hydrogen peroxides and leads to oxidative stress and 
ultimately neurodegeneration. 
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To investigate the interaction of Akt/Tkt/TKTL1 in vivo, CD1 fetal mice were 
transfected in utero with both the pCAGGS-hTKTL1 construct and pCAG-mRFP 
(monomeric red fluorescent protein) in collaboration with Roman Goz in the laboratory 
of Dr. Joe LoTurco186. Embryos were allowed to gestate until P0 and neocortex was 
extracted at this time. qRT-PCR was conducted to confirm the presence of hTKTL1 
transcript, as seen in the results in Figure 38. Immunoprecipitation was then performed 
on protein extractions using antibodies to Tkt, hTKTL1 or Akt as a control in this 
experiment. IP products were western blotted and stained with the antibody against 
phospho-threonine. This assay was performed to determine if phosphorylation of Tkt is 
inhibited by over expression of hTKTL1 in vivo. Figure 37 shows high expression of 
hTKTL1 transcripts in two mouse IUE brain samples, 11 and 13, compared to the non- 
transfected control. Moreover, endogenous Tkt expression appears unaffected in the 
transfected brains. 
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Figure 38: qRT-PCR of Mouse IUE Brain Samples 
Relative fold change of Tkt and TKTL1 in mouse IUE brain samples. A statistically significant 
increase in expression was observed in IUE brain 11 and 13 compared to WT. Error bars 
indicate 95 percent confidence interval. 
 
Immunoprecipitation and subsequent western blots of protein extracts from brain 
samples 11 and 13 are shown in Figure 39. Again, an increase in phosphorylation of 
TKTL1 when over expressed was observed along with a decrease in endogenous Tkt 
phosphorylation. Band concentrations were measured with ImageJ and an ANOVA 
single factor test was used to calculate statistical significance between IUE brain 
samples and WT. This data, combined with previously described protein data, provide a 
compelling argument that TKTL1 can and does act in competition with endogenous Tkt 
for phosphorylation. Inadequate levels of Tkt phosphorylation may lead to aberrant 
production of PPP metabolites and contribute to the levels of oxidative stress present in 
cells over expressing TKTL1. 
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Figure 39: Mouse IUE IP Western Blot Analysis 
Western Blot analysis on mouse IUE transfected samples compared to WT brain tissue. IP 
with Tkt antibody and blotted for phospho-threonine (A). IP with hTKTL1 antibody and blotted 
for phospho-threonine (B). Akt antibody used for total protein loading control (C). A decrease 
in phosphorylated Tkt was observed in IUE mouse brains compared to wildtype with a 
calculated *p-value=0.013. An increase in phosphorylation of hTKTL1 was observed in 
mouse IUE brains with a calculated *p-value=0.027. Histogram of densitometric quantification 
of band concentrations ratios to background and normalized to loading control (D). Akt used 
as total protein loading control. Secondary anti-body was provided by Li-cor. 
 
Conclusions 
 
With the lack of knowledge in the literature about the function of the TKTL1 
protein, providing insight into the role the protein plays in the PPP and the role of the 
conserved phosphorylation site was important. Protein-protein competition altering 
enzyme function has often been reported in the literature. This competition was clearly 
defined by the Csn4–Bam–Bgcn competition model where these proteins antagonize 
each other’s functions to regulate germ cell differentiation in D. melanogaster189. In  
this system, Bam proteins are upregulated and sequester the Csn4 proteins from the 
COP9 complex thus changing the function and allowing the cell to undergo 
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differentiation rather than self-renewal. My data suggests that  TKTL1 may very well  
be acting in a similar fashion regulating the function of endogenous  TKT in the PPP.  
In normal cells, low level expression of TKTL1 may modulate phosphorylation of TKT 
to achieve homeostasis. This would explain why TKTL1 is typically expressed at low 
levels as to not cause adverse effects to the PPP and increase levels of oxidative 
stress in the cell. However, when TKTL1 is over expressed in cancer cells, it is an 
important component in mass producing nucleic acids via increased levels of  
ribose190. Rapidly proliferating cancer cells increase glucose  consumption  as  a 
means to facilitate production of nucleotides and lipids191.  Several studies have  
shown TKTL1 to be a pivotal enzyme in the PPP in cancer cells and is hypothesized  
to be upregulated to balance the production pentoses for nucleotide synthesis and  
fatty acid synthesis, as well as maintaining homeostasis for oxidative stress191,192. 
TKTL1 may very well function as a transketolase in the PPP in cancer cells as studies 
have suggested. However, my experiments suggests a novel role for TKTL1 as a 
competitive inhibitor of TKT in neural cells. While TKTL1 expression and function has 
been well studied in cancer cells, its role in neural cells is currently unknown. 
Cascante et. al193 observed increased TKTL1 expression in cancer cells as well as 
increased activity of Akt and the mTOR signaling pathway. Increased Akt activation 
would allow for phosphorylation of both TKT and TKTL1. Additionally, Cascante et al. 
proposes TKTL1 functions in an independent one-substrate reaction converting 
xyulose-5-phosphate to glyceraldehyde-3-phosphate. Since neural cells are not  
rapidly dividing, TKTL1 may function differently compared to previous studies in  
cancer cells. In fact, the glutathione assay conducted by A. Friss (Figure 37) directly 
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contradicts TKTL1 functioning as a transketolase in neural cells. When TKTL1 is 
aberrantly expressed in normal neural cells, such as female parietal brain, oxidative 
stress and neurodegeneration may occur and lead to neurodevelopmental disorders 
such as ASD. 
Understanding how TKTL1 functions when it is over expressed  in  neuronal 
cells such as in these experiments can provide insight to the function it serves in 
neurotypical cells. This work has shown TKTL1 not only has a conserved Thr382 site 
with Tkt, but that it can alter the levels of Tkt activation as well. While TKTL1 is a 
relatively low expressed gene, it may be critical in modulating the function of the non - 
oxidative phase of the PPP. TKTL1 and Tkt could work together as the rate limiting 
enzymes in the PPP, based on phosphorylation activation. This data suggests TKTL1 
regulates and when over expressed, inhibits, the activation of Tkt. Using this 
antagonistic relationship between the two alleles, the cell is able to properly balance 
the reversible reactions of the non-oxidative phase of the PPP to ensure oxidative 
stress is kept low, while also producing metabolites for downstream functions such as 
the production of DNA/RNA. As no studies to date have investigated the function of 
TKTL1 in neural cells, this body of work serves as a novel insight into how TKTL1 
functions within neural cells, and in particular how it can be used to regulate the PPP. 
While TKTL1 may in fact not function as a transketolase itself due to the deletion of  
the co-enzyme binding site, this study suggests it does play a role in overall 
transketolase function within the cell. Additionally, the data  suggests  that  when 
TKTL1 is over expressed within neural  cells, oxidative stress is increased and can  
lead to neurodegeneration, and potentially, ASD. 
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Chapter 6: Synthesis and Future Directions 
 
The goal of past graduate students in the O’Neill lab has been primarily to 
elucidate an imprinting mechanism regulating PSGE on the X chromosome in 
mammals. This began with Dr. Raefski and his discovery of the imprinted Xlr3/4 cluster 
in 20053. Using a Turner Syndrome model mouse, this study identified maternal specific 
gene expression of the Xlr3b, Xlr4b, Xlr4c paralogs on the XA.7.2 region of the X 
chromosome. The imprint was observed in different tissue types including brain and 
fibroblast cell lines. Following this work Dr. Carone proposed that a novel imprinting 
mechanism must exist regulating the imprinted cluster after providing evidence that a 
DMR does not exist within the region of the imprinted paralogs. 
Looking at the primary transcripts of Xlr3b Dr. Kasowitz identified a difference in 
transcript abundance at the 3’ end that was not seen at the 5’ end when comparing the 
maternal to paternal alleles. This suggested that the maternal copy of Xlr3b completed 
transcription through initiation, elongation and termination while the paternal transcript 
was interrupted after initiation. Building off of this work, Dr. Qureshi sought to 
investigate the potential co-transcriptional regulation mechanism studying RNA Pol II 
activity at the Xlr3/4/5 locus. Through his experiments he showed a perturbation of RNA 
Pol II during active transcription first beginning at Int3/Ex4 and almost completely stalled 
by intron 7. However, Dr. Qureshi’s results have not been able to be repeated by others 
in the O’Neill lab. This previous work culminated in the study of various histone 
modifications at the imprinted Xlr3/4 region to investigate if a differential chromatin 
environment exists between the maternal and paternal allele potentially influencing 
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active RNA Pol II transcription events. Prior to this dissertation, no robust, repeatable 
difference in chromatin architecture has been observed. 
Dr. Nesbitt established the foundation for the work investigating TKTL1 (Tktl1) in 
both human and mouse. Dr. Nesbitt searched beyond the imprinted Xlr cluster in an 
attempt to identify other imprinted genes on the mouse X chromosome. In doing so, she 
identified the gene Tktl1 to be partially paternally imprinted in specific mouse tissues 
including subregions of the neonatal brain. The unique finding by Dr. Nesbitt enabled 
the lab to bridge the gap between the model mouse and the human genome since, 
unlike the Xlr3/4 genes, Tktl1 has a human ortholog, TKTL1 that is also present in the 
syntenic region of the human X chromosome174. Her work along with Amy Friss 
identified Tktl1 to not only be imprinted, but also involved in the pathway of glutathione 
reduction. This discovery linked an imprinted gene on the X chromosome to potential 
downstream neurodegeneration and cognitive defects for the first time in our lab. I 
began my work studying the relative expression of TKTL1 in human brain sub-regions to 
test the hypothesis that individuals with ASD would aberrantly express TKTL1 and thus 
would have neurodegenerative and social cognitive defects. I also set out to investigate 
the function the TKTL1 protein plays in the Pentose Phosphate Pathway to test the 
hypothesis that over expression of TKTL1 would decrease the phosphorylation and 
activation of endogenous Tkt altering production of metabolites in the non-oxidative 
phase of the PPP. 
Nucleosome Positioning and the RNA Pol II Stalling 
 
A thorough investigation of nucleosome positioning and occupancy has shown 
that there are regions on the paternal allele of the imprinted Xlr genes that are highly 
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nucleosome dense compared to the maternal allele, and that regions of the maternal 
allele contain nucleosomes not present on the paternal allele. Specifically in Xlr3b, 
nucleosomes are preferentially positioned proximal to the Int3/Ex4 boundary and within 
intron 7 on the paternal allele. Although this is not a definitive answer to the stalling 
machinery or imprinting control mechanism of X-linked imprinted genes, it does provide 
a novel insight into how nucleosome positioning can potentially influence transcription 
regulation on the X chromosome. Low levels of paternal mRNA transcripts are 
detectable suggesting that RNA Pol II is able to overcome the nucleosome obstacles on 
the paternal allele but at a relatively low success rate. Additionally, the presence of a 
maternal nucleosome located at the G-quadruplex exon1/intron1 boundary suggest a 
potential novel mechanism where H3.3 may be deposited on the maternal allele and not 
the paternal allowing proper transcription initiation and elongation. H3.3 would only be 
able to be deposited on the maternal allele alleviating the secondary G-quadruplex 
structure and allowing proper transcription throughout the gene body. Conversely, on 
the paternal allele, H3.3 would not be deposited in the region of G-quadruplex formation 
and RNA Pol II would not be able to proceed effectively though the gene body. 
A future characterization of transcription differences between the alleles could be 
investigated by conducting a global run on sequencing (GRO-Seq) assay to determine 
the status of RNA Pol II and the transcripts being produced from the maternal and 
paternal alleles175. Since the paternal allele is not producing a full transcript, the 
maternal sequencing results for the imprinted Xlr3/4 region should be statistically more 
prevalent. Additionally, this assay would indicate the status of RNA Pol II across the 
gene body for each of the imprinted paralogs providing a more in depth understanding 
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about the stalling mechanism as a whole. Conducting this GRO-Seq experiment with 
the Illumina Next-Seq would allow for a thorough investigation of the maternal and 
paternal X chromosome and help identify other genes with a similar profile. This 
process will map the quantity, orientation and position of actively transcribing RNA Pol 
II. 
An assay should be developed to destabilize the nucleosomes present on the 
paternal allele to observe if full active transcription is restored to provide evidence that 
nucleosome positioning is influencing transcriptional regulation. Nucleosome 
destabilization has been used to allow nucleosomes to be more easily modified during 
transcription176. One way to destabilize nucleosomes is to alter the salt concentration in 
in vitro expression assays. Nucleosome binding affinity can be altered by increasing or 
decreasing the overall salt concentration loosening or tightening the bound DNA 
allowing for easier histone octamer sliding events195. If nucleosome binding affinity is 
lessened and normal levels of transcription are restored, it could be concluded that 
specific nucleosome positioning perturbs RNA Pol II and in effect, regulates 
transcription of the imprinted cluster. It is important to thoroughly investigate this 
nucleosome occupancy and RNA Pol II activity as a potential imprinting mechanism and 
would require further evidence to conclusively characterize it as a novel imprinting 
mechanism. GRO-Seq and a nucleosome sliding assay would greatly contribute to this 
hypothesis. 
An additional assay that would aide in deciphering the role of G- 
quadruplex/ATRX interactions would be a histone variant H3.3 ChIP-Seq. This 
experiment would determine if there is differential deposition of H3.3 on the maternal 
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allele compared to the paternal allele at the exon1/intron1 boundary. H3.3 is known to 
be deposited in heterochromatic regions of DNA to allow for DNA accessibility for active 
transcription177,178. If there is an enrichment of H3.3 at this locus on the maternal allele it 
would explain how RNA Pol II is able to produce a full transcript of Xlr3b on the 
maternal allele and explain why the paternal allele remains repressed. To determine if 
this H3.3 deposition truly is the ICR controlling the imprint of Xlr3b, an assay would 
need to be conducted to either remove H3.3 from the maternal allele where the 
expected outcome would be transcription silencing, or add H3.3 to the paternal allele 
where the expected outcome would be transcription activation of the paternal allele. An 
RNAi construct could be created against histone variant H3.3 thus interfering with the 
deposition on the maternal allele. In this assay, the hypothesis would be the maternal 
allele would not produce a full transcript and would become silent. 
The Model of Xlr3b Transcription Perturbation by Nucleosome Occupancy 
 
For the purposes of this dissertation, the model of transcription perturbation 
identifies nucleosome occupancy on the paternal X chromosome to regulate expression 
at the Xlr3/4 imprinted gene cluster. The maternal allele of Xlr3b undergoes proper 
transcription initiation, elongation and termination. The maternal copy is 
hypermethylated at the promoter and transcription initiation events are observed 
similarly to autosomal imprinted loci in the genome. Although the promoter region is 
heavily methylated the pre-initiation complex (PIC) is able to be established successfully 
and RNA Pol II begins to synthesize mRNA products198,199. This is followed by proper 
transcription elongation and eventually termination at the 3’ end of the gene200. 
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The paternal allele does not follow the same pattern of transcription elongation. 
 
Previous data by Dr. Carone, Murphy and Kazowitz have suggested that the PIC is able 
to successfully establish at the Xlr3b promoter and begin to synthesize mRNA. Early 
transcription events occur equally on both the maternal and paternal allele up through 
part of transcription elongation. Following this initiation of transcription, RNA Pol II 
appears to be interrupted on the paternal allele failing to produce a full length paternal 
transcript. As of yet, no mechanism or model has been reproducible to explain this 
paternal silencing. The following model, shown in Figure 40, explains an imprinting 
mechanism where differential nucleosome positioning may cause RNA Pol II to stop 
and dissociate during active transcription on the paternal allele. A buildup of 
nucleosomes results in the perturbation of RNA Pol II on the paternal allele followed by 
dissociation. The following model provides a schematic of how nucleosome positioning 
could cause RNA Pol II elongation perturbation and eventual dissociation from the DNA 
strand. Weber et al.201 explains that nucleosomes are observed to create a barrier to 
RNA Pol II transcription in vitro. This study showed that nucleosome occupancy has a 
direct effect on the extent of RNA Pol II stalling and perturbation201. The ability of 
nucleosomes to pause RNA Pol II transcription is well defined in the literature, 
particularly at the promoter region. Gilchrist et al. noted highly regulated genes with 
nucleosomes at the promoter that display RNA Pol II stalling, disfavor nucleosome 
occupancy within the gene202. This data suggested a link between RNA Pol II competing 
with nucleosomes for promoter occupancy and downstream positioning of nucleosomes 
within the gene body. Nucleosome positioning at highly active gene sites has been 
observed to create a stalling event just upstream of the transcribed gene region. This 
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barrier is required to be overcome for downstream transcription to occur203. Wilhelm et 
al. hypothesized that a pile up of nucleosomes at the intron/exon boundary could cause 
RNA Pol II to slow down or pause204. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40: A Proposed Imprinting Mechanism Model Silencing the Paternal Xlr3b 
Proper transcription initiation occurs on both the maternal and paternal alleles and actively 
being transcribing mRNA. When RNA Pol II approaches int3/ex4, it encounters specifically 
placed high affinity nucleosomes and begins to stall. This stall inhibits the ability of the 
transcription machinery to recruit chromatin remodelers and thus creates an environment 
difficult for the machinery to transcribe through. Some RNA Pol II is able to overcome the 
first obstacle, but further downstream RNA Pol II encounters another region of high affinity 
nucleosomes at intron 7 and the majority of RNA Pol II is stalled and dissociated truncating 
transcription and causing the silencing of the paternal Xlr3b transcript. 
An alternative model for the Xlr imprinting cluster could involve a G-quadruplex 
recruitment of ATRX on the maternal allele leading to the deposition of H3.3 to provide 
active RNA Pol II transcription at the 5’ end of the Xlr3b gene body. This novel 
mechanism would explain how the maternal allele is expressed more freely while the 
paternal allele remains repressed. In this model seen in Figure 41, a G-quadruplex at 
the exon1/intron1 boundary of the Xlr3b gene body would recruit ATRX to the region 
where there is a differential nucleosome occupancy between the maternal and paternal 
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alleles. The maternal allele which has an observed nucleosome located at this locus 
would allow ATRX to deposit H3.3 to promote active transcription of the allele. 
Conversely, the paternal allele, would contain no nucleosome placed at this G- 
quadruplex region and would not allow deposition of H3.3 and would inhibit the ability of 
proper transcription elongation of the allele in a parent specific manner. This novel 
mechanism would be the first of its kind on the X chromosome to describe a genomic 
imprinting region utilizing ATRX at a G-quadruplex to regulate parent specific gene 
expression. Additionally, the Shioda group identified a small CG rich region that 
displayed differential methylation in their male ATRX knockout mice. In the study, ATRX 
KO mice displayed a decrease in methylation at the region compared to WT178. 
Although this region is not a classically identified CpG island, this differential 
methylation of the region could be involved with the imprinting mechanism. However, 
previous work by Dr. Carone and Dr. Murphy did not detect differential methylation in 
this region. 
Additionally, the transcription factor complex, FAcilitates Chromatin Transcription 
(FACT), is essential for chromatin remodeling and proper transcription through 
nucleosomes205. When RNA Pol II stalls at the 5’ region of genes, H3K36me3 also piles 
up with the transcription machinery. Set2, a histone methyltransferase, modifies 
histones with H3K36me3 in coordination with RNA Pol II during transcription 
elongation206,207. If H3K36me3 cannot be recruited properly, i.e. due to a lack of a 
nucleosome, FACT recruitment will also be altered and the ability of active transcription 
could be drastically diminished. This may be involved with the perturbation of RNA Pol II 
on the paternal allele along with overcoming a G-quadruplex on the maternal allele. 
97  
 
 
 
Figure 41: Proposed Alternative Imprinting Mechanism Model for Xlr3b 
Proper transcription initiation occurs on both the maternal and paternal alleles and 
actively being transcribing mRNA. However, at the exon1/intron1 boundary a 
nucleosome is positioned on the maternal allele and not the paternal allele. This 
positioning difference allows for ATRX, which is recruited to the G-quadruplex region of 
the gene body and deposits H3.3 to regulate active gene transcription. Conversely, on 
the paternal allele, this nucleosome does not exist at the exon1/intron1 boundary and 
thus does not allow for H3.3 deposition and transcript regulation is decreased due to 
RNA Pol II difficulty transcribing through the region. This is exacerbated further down the 
gene body by a pile-up of nucleosomes on the paternal allele perturbing any residual 
RNA Pol II from successfully transcribing the Xlr3b transcript and thus silencing the 
paternal allele. 
 
 
 
 
TKTL1 Expression in Human ASD Brain Sub-regions 
 
Oxidative stress has been closely linked to the development of 
neurodegenerative disorders such as ASD208,209,210. The literature has connected over 
expression of TKTL1 to increased levels of oxidative stress in certain cancers including 
colorectal211 and several carcinomas212. TKTL1 upregulation has been identified as a 
necessary event for tumor cells to proliferate and degrade glucose through the 
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anaerobic transketolase-dependent PPP, known as the Warburg effect, for tumor cell 
proliferation189. Due to this link to the PPP and production of substrates through the 
degradation of glucose, TKTL1 is also linked to cellular oxidative stress by influencing 
the reduction of glutathione to interact and reduce reactive oxygen species in the 
cell208,209,210. This role directly links Transketolase activity to the development of 
neurodegenerative disorders such as ASD along with cancer9. When I analyzed the 
relative expression of TKTL1 I expected to find over expression prevalent in autistic 
males due to the approximately 5:1 ratio of ASD in males to females1. However, the 
data showed no statistical significance in either parietal or occipital brain tissue for 
autistic males but did show a statistically significant difference in TKTL1 expression in 
autistic female parietal brain samples. This observation can be explained by the Female 
Protective Effect20 which states that females require a greater etiologic load to manifest 
autistic behavioral impairment and thus this upregulation of TKTL1 in males may be 
embryo lethal or so detrimental that the outcome is not ASD, but a more severe 
neurological disorder. Another possible explanation is that male samples obtained for 
this study were collected at varying post mortem intervals (PMI), and among them there 
was a high rate of asphyxiation related causes of death. These factors could have made 
it more difficult to observe a statistically significant difference in male TKTL1 expression 
assays. It has been hypothesized in the literature that a single X chromosome locus 
could mediate the Female Protective Effect and in turn produce the male sex bias 
observed in ASD21. This also supports the hypothesis of Skuse et al. that there are 
imprinted genes on the X chromosome responsible for deficits in neurocognitive ability2. 
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An approximate 3-4 fold increase of relative TKTL1 expression was observed in 
brain samples from autistic females obtained from the Neurobiobank. This data 
suggests a sub-region specific increase of TKTL1 may contribute to the etiologic load in 
females resulting in the development of neurodegenerative disorders such as ASD. Dr. 
Nesbitt had previously identified TKTL1 to be imprinted in human fetal brain and this 
imprint could support the Skuse hypothesis of imprinted X chromosome genes 
influencing neurocognitive acuity. Data of this imprint was also supported by my SNP 
identification assay where monoallelic expression of TKTL1 was observed in 
neurotypical female parietal brain samples while biallelic expression was observed in 
ASD female parietal brain samples. This data suggests that there is a genomic imprint 
of TKTL1 on the human X chromosome even in adulthood and a subregion-specific loss 
of this imprint could lead to aberrant expression of TKTL1 and eventually the 
development of neurodegenerative disorders. 
It would be important to investigate these findings in a larger representative 
sample of individuals to give higher confidence this effect is taking place. An N=4 for 
both female neurotypical and ASD brain samples does suggest a pattern of expression 
for TKTL1. Repeating these experiments with additional cohorts would greatly increase 
the significance of the finding and add to the overall knowledge of female ASD 
development and potential therapeutic interventions in the field. However, it would be 
important to ensure the samples provided were from identical brain sub-regions. 
Another further experiment that would provide insight into the development of ASD 
would be RNA-Seq. Using the Illumina Next-Seq to sequence the RNA profile of ASD 
brain sub-regions would give an overall view of transcript differences across the entire X 
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chromosome. Comparing neurotypical brain RNA-Seq data to ASD data would provide 
inferences to differentially expressed regions and genes on the X chromosome and 
would allow for identification and further analysis of gene targets. Understanding the 
development of ASD is very important with the pervasive nature of the disorder and a 
larger sample size along with RNA-Seq would contribute to the collective knowledge in 
the field of ASD. 
TKTL1 Protein Function and Influence on Endogenous Tkt 
 
As previously discussed, transketolase is a rate limiting enzyme in the PPP 
regulating production of products to ensure proper cell homeostasis during the non- 
oxidative phase158,171. TKTL1 has been implicated in neurodegenerative disorders such 
as ASD and schizophrenia along with several forms of cancer including colorectal, 
breast and other carcinomas189,190. However, the overall function and role of the protein 
itself is not well classified in the literature. In fact, there is a disagreement whether 
TKTL1 even maintains functional transketolase activity152. With this lack of knowledge in 
the literature, investigating the function of TKTL1 and determining its role in the PPP 
was important to this body of work. To do this I transfected HT22 hippocampal mouse 
cell lines with the human TKTL1 cDNA transcript. In doing this I aimed to elucidate the 
relationship between TKTL1 and endogenous Tkt. Previously in this dissertation TKTL1 
and Tkt were explained to share a conserved phosphorylation site, Thr382, which has 
been shown to be essential for Tkt activation and proper function. Akt as part of the 
mTOR pathway phosphorylates Tkt at Thr382 activating the enzyme and allowing it to 
function properly in the PPP catalyzing reactions of substrates in the non-oxidative 
phase145. Knowing this phosphorylation is essential for Tkt activation, I hypothesized 
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that because of the conserved Thr382 domain, TKTL1 would act in competition with Tkt 
for phosphorylation and thus reduce the presence of activated Tkt in cells. As the data 
showed, TKTL1 was in fact phosphorylated by an interaction with Akt and subsequently 
the total amount of phosphorylated Tkt was reduced. 
Additionally, transgenic mice were generated with the help of Roman Goz of the 
LoTurco laboratory. CD1 fetal mice expressed TKTL1 transcript within the brain after In 
Utero Electroporation (IUE). Extracting the brain tissue from these mice at P0, the 
interaction of TKTL1 and Tkt was investigated in vivo and the same competitive 
phosphorylation was observed. A constitutively active TKTL1 construct could be 
engineered to over express TKTL1 specifically in mouse brain. This experiment would 
generate transgenic mice with a similar expression profile to female ASD individuals 
and could be used to further investigate the effects of TKTL1 over expression on the 
PPP and overall brain development. Potentially this model could be used for behavioral 
studies to determine if the mice present an ASD phenotype by decreased learning, 
repetitive behavior, and social deficiency. 
A transgenic Tkt knock-out cell line could be generated to study the function of 
Tktl1. To elucidate whether Tktl1 truly maintains the transketolase activity, these cell 
lines could be treated with an integrating Tktl1 expression vector to determine if over 
expressing Tktl1 would rescue the cell line, thus proving that Tktl1 can in fact function 
as a transketolase in the PPP. This could prove to be a difficult experiment as knocking 
out Tkt would potentially drastically inhibit the cells ability to proliferate213. However, if 
Tktl1 is able to rescue the cell line and allow them to proliferate it would provide 
substantial evidence supporting Tktl1 transketolase activity. With how pervasive TKTL1 
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is in the literature relating to such prevalent disorders such as ASD and cancer, it is 
important to examine the function of the protein thoroughly. Thus far in the literature, the 
overall function of the protein has yet to be classified and these transgenic models 
would contribute to the knowledge of TKTL1 in the field and provide crucial insight to the 
role the gene plays in both neurodegenerative disorders and cancer. 
The following models (Figures 42&43) depict the proposed competition observed 
in the data examined in this dissertation. The data suggests that TKTL1 actively 
competes with Tkt for phosphorylation by Akt. This competition inhibits the activation of 
Tkt and ultimately leads to higher levels of oxidative stress in the cell due to the inability 
of Tkt to function properly in the non-oxidative phase of the PPP. This lack of catalyzing 
reactions results in a decrease in NADPH production lowering the amount of reduced 
glutathione able to interact and reduce reactive oxygen species like hydrogen peroxide. 
High levels of ROS in the cell leads to oxidative stress, lipid peroxidation, and 
neurodegeneration. This provides the first direct link in the literature between TKTL1 
and how it potentially leads to the development of neurodevelopmental disorders such 
as ASD. 
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Figure 42: Model of Typical TKTL1 Phosphorylation 
Endogenous Tktl1 is expressed in low levels in mouse. When properly regulated and 
expressed, it does not interfere with the phosphorylation and activation of Tkt by Akt and 
activated Tkt is able to function properly in the PPP. Tkt limits the reaction and conversion 
between Ribulose 5-phophate and Glucose 6-phosphate and regulates the production of 
NADPH and reduced glutathione. 
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Figure 43: Competition Model of Over Expressed TKTL1 in the PPP 
Over expression of TKTL1 in the cell creates a competition for Akt phosphorylation. When 
TKTL1 is over abundant, Akt will phosphorylate TKTL1 instead of endogenous Tkt. 
Phosphorylated TKTL1 is then responsible for catalyzing the reaction in the non-oxidative 
phase of the PPP. Even if TKTL1 retains the transketolase active, over expression will alter 
the precursors and products in the PPP. This can result in deleterious effects to NADPH 
production and lower the amount of reduced glutathione that is able to function as an 
antioxidant and reduce ROS lowering oxidative stress. This model displays a potential 
pathway for the increase of oxidative stress in neurons and eventual neurodegeneration 
seen in disorders such as ASD. 
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Chapter 7: Materials and Methods 
Animal Breeding and Tissue Collection 
 
All mouse protocols were approved by the University of Connecticut Institutional 
Animal Care and Use Committee. A breeding scheme was used to generate X- 
monosomic mice with a C57 strain background, (Figure 3). C3H/Paf males were mated 
to C57BL/6J females to produce 39, XM mice. C3H/In(X) females were mated with 
C57Bl/6J males to produce 39,XP mice. Neonates were inspected visually to initially 
determine sex. A DNA extraction from limb tissue was conducted for PCR genotyping 
using proteinase K digestion. A Y chromosome specific primer set, Smcy, was used to 
definitively sex the mice. The DXMit130 marker primer set was used to determine 
between the C56 and C3H X chromosome. 
RNA Extractions 
 
Tissue was extracted from mouse, flash frozen in liquid nitrogen, and stored at - 
80 until use. Human brain tissue was obtained already frozen from the Chuahan lab and 
from the Maryland Brain Bank and stored at -80. Brain tissue from both mouse and 
human were finely chopped with a scalpel and resuspended in buffer. Tissue and cell 
pellets were extracted with Qiashredder (Qiagen) and RNeasy spin columns (Qiagen) 
and suspended in DI water. 
Bisulfite Sequencing 
 
Chromatin was extracted from mouse 39,XM and 39,XP brain tissue samples. 
 
Samples were treated with bisulfite conversion reagent (Zymo) at 42°C overnight. 
Samples were purified and amplified using bisulfite primer sets designed with Zymo 
Bisulfite Primer Seeker (Primer Table). Samples were run on the Sanger 3130 and 
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sequence peaks were viewed with FinchTV. Methylated DNA diagrams were generated 
using BiQ Analyzer from the Max Planck Institute bioinformatics. 
Quantitative Real-Time PCR 
 
SYBR Green Supermix (Quanta was used to perform qRT-PCR. Each sample 
was conducted in triplicate with a 15 uL reaction volume on an IQ thermocycler from 
BIORAD. The following protocol was used on the cycler; initial denature (95°C for 5 
min); amplification step (95°C for 10 s, 62°C for 20 s, 72°C for 20 s); and final extension 
step (72°C for 5 min). All primers used for qRT-PCR are provided in the supplemental 
table of primers. Melt curves and CT values were analyzed using CFX Manager from 
BIORAD for multiple products and primer efficiency. CT values were determined and 
normalized using the relative expression ratio mathematical model (Pfaffl). Significance 
was calculated with a T-Test. 
Micrococcal Nuclease Treatment 
 
Chromatin was extracted from neocortex of three 39,Xm individuals and three 
39,Xp individuals via Phenol Chloroform/Isoamyl extraction. The chromatin was digested 
with 0.5 units of micrococcal nuclease (NEB, MNase) for one hour at 37°C followed by a 
proteinase K digestion leaving only previously nucleosome bound DNA. DNA was 
suspended in DI water and analyzed on the Bioanalyzer DNA chip for library size 
quality. Expected samples sizes were for 147 bp fragments. 
SureSelect Target Enrichment 
 
Custom SureSelect (Agilent) cRNA baits were created using the SureDesign 
Tool (Agilent). Baits were created on the Mus Musculus X chromosome from 
chrX:(70,319,680-70,535,867) from the mm9 build (NCBI 37.1). cRNA baits were 
107  
hybridized according to Agilent SureSelect protocol binding previously treated MNase 
digested DNA samples and suspended in DI water. 
Illumina Mi-Seq Sequencing 
 
SureSelect target enrichment samples were used to create Illumina Mi-Seq 
libraries. Six libraries were made for the three 39,Xm, and three 39,Xp brain tissue 
samples. Custom SureSelectXT for Illumina Mi-Seq was used to generate libraries. 
Illumina Mi-Seq adapters were added and sequences were paired end. Libraries were 
quantified on the Bioanalyzer using a DNA HS chip (Agilent). Samples were loaded onto 
Mi-Seq with the help of Dr. Bo Reese of the CGI. 
Initial data was analyzed with a FastQC report to assess the quality of the run. 
 
Bowtie2 was used to map Mi-Seq reads to the Mus musculus mm10 build (GRCm38) as 
a reference index genome. Mapped reads were then analyzed with the R packages 
NucleR and PING. PING generated a nucleosome positioning map utilizing peak 
detection. NucleR generated a bed file of the nucleosome positions that could be 
uploaded to UCSC and compared to other functional elements in the genome. 
Bedsubtract was used to generate uniquely mapped reads for the XM and XP alleles. 
NormR was also be used to normalize sequencing data and call enrichment of peaks. 
Bionano Genomics Methylation Protocol 
DNA was extracted from mouse 39,XM and 39,XP neonatal fibroblast tissue 
cultures. Agarose plugs were made for high molecular weight extraction using the 
CHEF Mammalian Genomic DNA kit (BIORAD) Cells were harvested and pelleted in 
collection tubes at 1000 RPM for 5 minutes. Following this, the plugs are washed with 
Wash Buffer and TE Buffer for iterations of 10 minutes at 43°C. Cells are embedded 
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into agarose in a 15 minute incubation at 4°C. Next, there is a 2 hour proteinase K 
digestion at 50°C followed by an overnight digestion also at 50°C. Plugs are washed 
with wish buffer while shaking for a total of 2.5 hours at room temperature. The agarose 
plugs are then melted during a 2 minute incubation at 70°C. Agarose is digested with 
agarase during a 45 minute incubation at 43°C followed by a drop dialysis for 45 
minutes at room temperature. DNA is homogenized overnight at room temperature to 
get into solution. A dialysis membrane is used to isolate high molecular weight (HMW) 
DNA. A Qbit Broad Range DNA analysis determines the concentration of the HMW 
DNA. 300 ng of DNA digested with cofactor Adocf640 and M.TaqI enzyme for five hours 
at 65°C. Proteinase K is added for two hours at 45°C. 
The NLR reaction consists of a nick, label and repair. HMW DNA is nicked with 
the BspQI enzyme for two hours at 37°C. The reaction then is labeled with the Bionano 
labeling mix for one hour at 72°C. Finally the reaction is repaired with ligase for thirty 
minutes at 37°C. The DNA backbone is stained with the Bionano staining mastermix 
overnight at 4°C. The NLR reaction is quantified using the Qbit DNA HS assay. 
The sample is loaded onto the Bionano Irys and a sample specific loading 
protocol is produced with via assisted loading on the machine. Molecules are identified 
by the program AutoDetect and data is analyzed on IrysView, Bionano Access and 
IrysExtract. 
Illumina NextSeq OMNI-ATAC-Seq 
 
Mus musculus 39XM and 39XP neonate neocortex were extracted from mice. 
Tissue was homogenized in 1x Homogenization buffer with Dounce homogenizer. 
Nuclei were isolated through gradation by layering 35%, 29%, and 25% Iodixanol 
109  
solution, separating cellular debris and the nuclei band. Nuclei were counted with 
Trypan blue staining and 50,000 nuclei (Mus musculus) and 500 (Drosophila) nuclei 
(spike in) were treated with ATAC-Seq Resuspension buffer followed by transposase 
reaction buffer to attach preloaded Illumina adapter sequences. Samples were Pre- 
Amplified for 5 cycles with 2x NEBNext Master Mix and Illumina adapter and index 
primers (Primer Table). Cycling conditions; 72°C for 5 minutes, 98°C for 30 seconds, 
followed by five cycles of 98°C for 10 seconds, 63°C for 30 seconds and 72°C for 1 
minute. A qPCR reaction was conducted to assess additional cycles needed for 
amplification. Cycling conditions; 98°C for 30 seconds followed by 20 cycles of 98°C for 
10 seconds, 63°C for 30 seconds and 72°C for 1 minute. Guidelines followed for 
amplification found in Buenrostro et al 2015 (PMID: 25559105). Library was quantified 
with KAPA Library Quantification kit and run on Illumina NextSeq with High-Output kit 
2x75 paired end reads. 
Initial data was analyzed with a FastQC report to assess the quality of the run. 
 
Bowtie2 was used to map Mi-Seq reads to the Mus musculus mm10 build (GRCm38) as 
a reference index genome. Mitochondrial reads will be removed before building the 
genome index. Peaks will be called using MACS2 and compared similarly as ChIP-Seq 
data for enrichment between 39XM and 39XP samples. DNA footprint analysis will be 
conducted with ATAC-Seq pipeline according to Kundaje lab script on GitHub. 
Nucleosome positioning was analyzed using NucleoATAC developed by the 
Greenleaf lab at Stanford University generating nucleosome occupancy maps. 
Following that, DNA footprint analysis was conducted with the MEME suite to detect 
transcription factor binding proteins within the Xlr3b open chromatin DNA. 
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Transfection 
 
Mus musculus hippocampal neuronal cell lines (HT-22) were cultured in 
complete mouse media. A pCAGGs hTKTL1 plasmid (gift from Dr. Loturco and altered 
by Dr. Nesbitt for hTKTL1) was transfected into cells with the Neon Transfection System 
(ThermoFisher). Cells were viewed under CKX41 (Olympus) florescent microscope to 
confirm the presence of GFP expressing cells to calculate transfection efficiency. Cells 
were harvested in cell pellets and divided into tubes for RNA and protein extraction. 
qRT-PCR was performed on cDNA to confirm upregulated expression of human TKTL1 
in transfected mouse HT-22 cells. 
Western Blot 
 
Protein was extracted from HT-22 cell pellets with Laemmli lysis buffer and 
protease inhibitors. Laemmli loading buffer was added to protein samples and incubated 
at 95°C for 5 minutes before loading in gel. 12% SDS page gels were made with the 
SureCast system (ThermoFisher) with a 4% stack for wells. Samples were loaded and 
ran at 125V for 90 minutes. Samples were then transferred to a PDVF membrane by 
wet transfer with the ThermoFisher SureCast System at 20V for 60 minutes. 
Membranes were allowed to dry for 1 hour at room temperature to allow proteins to 
properly bind to the membrane. Following this membranes were reactivated in methanol 
for 1 minute and blocked in 50% Licor Blocking Buffer and 50% 1X PBS for 1 hour. 
Membranes were blotted with 1° antibody at a dilution of 1/1000 in a 50% Licor Blocking 
Buffer and 50% 1X PBS solution with 0.01% Tween for 1.5 hours at room temperature. 
Membranes were then washed 4x 5 minutes in 1X PBS + 0.1% tween. The 2° antibody 
was added in a 1/10000 dilution same blocking solution with 0.1% tween. Membranes 
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were then washed 4x for 5 minutes in blocking solution with tween followed by a final 
wash in 1X PBS for 5 minutes. Western blots were imaged and analyzed on the Licor 
system using a Chameleon Duo protein ladder. Densitometry calculations were 
conducted with ImageJ following the ImageJ protocol for subtracting background. 
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Appendices 
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Figure S1: MNase-Seq Quality Score: 
Average read quality for 39XM sample Xm73 (A) and 39XP sample Xp100 (B). Sequence 
length observed ~150 bp for majority of reads in 39XM sample Xm73 (C) and 39XP sample 
Xp100 (D). 
B 
D 
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Figure S2: ATAC-Seq Run Quality Report 
The average read quality for (a) 39,XM and (b) 39,XP samples approximately 35 on the 
Phred+33 scale. A high quality Phred+33 score exists for both (c) 39, XM and (d) 39, XP 
pools meaning only adapter trimming will be necessary for these reads. The read length 
going into mapping for (e) 39, XM and (f) 39, XP samples is distinctly 75bp. 
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Figure S3: pCAGGS Vector Map 
Vector used for transfections and IUE protocols of hTKTL1 cDNA transcripts. Commercially 
available. Utilized glycerol stocks from Dr. Nesbitt and Amy Friss. 
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Figure S4: 39,XM ATAC-Seq Quality Metrics 
(A) Proximal Transcription Start Site (TSS) enrichment. Represents enrichment around 
individual TSS’s. (B) Represents aggregated enrichment at all TSS’s. (C) Fragment length 
distribution of ATAC-Seq reads. Majority of sequences within nucleosome free regions 
(<150 bp) ~75 bp. (D) Signal correlation to roadmap DNase (ENCODE) from several 
sample types measured by the Spearman’s Correlation. The closer the sample is in signal 
distribution in the regions to your sample, the higher the correlation. Of note, the highest 
correlated tissues are all members of the central nervous system (CNS). 
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Figure S5: 39,XP ATAC-Seq Quality Metrics 
(A) Proximal Transcription Start Site (TSS) enrichment. Represents enrichment around 
individual TSS’s. (B) Represents aggregated enrichment at all TSS’s. (C) Fragment length 
distribution of ATAC-Seq reads. Majority of sequences within nucleosome free regions (<150 
bp) ~75 bp. (D) Signal correlation to roadmap DNase (ENCODE) from several sample types 
measured by the Spearman’s Correlation. The closer the sample is in signal distribution in 
the regions to your sample, the higher the correlation. Again, the highest correlation exists 
within neurological CNS tissues. 
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Sample ID Age Sex Disorder Cause of Death PMI 
1174 7.8 F ASD Multi-system failure 14 
1182 9 F ASD Smoke Inhal. 24 
1638 20.8 F ASD Seizure-related 50 
4671 4.6 F ASD Fall 13 
1407 9.1 F Control Asthma 20 
1706 8.6 F Control Transplant rejection 20 
1708 8.1 F Control Car Accident 20 
1846 20.6 F Control Car Accident 9 
0797 9.3 M ASD Drowning 13 
1349 5.6 M ASD Drowning 39 
4231 8.8 M ASD Drowning 12 
4849 7.5 M ASD Drowning 20 
4899 14.3 M ASD Drowning 20 
5027 38 M ASD Bowel obstruct. 26 
1185 4.7 M Control Drowning 17 
1500 6.9 M Control Car Accident 18 
4645 39.2 M Control Heart disease 12 
4670 4.6 M Control CC accident 17 
4722 14.5 M Control Car Accident 16 
4898 7.7 M Control Drowning 12 
 
 
Figure S6: Table of Neurotypical and ASD Brain Sub-Region Samples 
Table depicts subject ID’s and related information for samples. Of note for this body of 
work, the high prevalence of drowning or asphyxiation related causes of death and Post- 
mortem interval (PMI). 
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Primer Table 
 
Primer Name Sequence 
Ad1_noMX AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTCAGATGTG 
Ad2.1_TAAGGCGA CAAGCAGAAGACGGCATACGAGATTCGCCTTAGTCTCGTGGGCTCGGAGATGT 
Ad2.2_CGTACTA CAAGCAGAAGACGGCATACGAGATCTAGTACGGTCTCGTGGGCTCGGAGATGT 
Ad2.3_AGGCAGAA CAAGCAGAAGACGGCATACGAGATTTCTGCCTGTCTCGTGGGCTCGGAGATGT 
Ad2.4_TCCTGAGC CAAGCAGAAGACGGCATACGAGATGCTCAGGAGTCTCGTGGGCTCGGAGATGT 
G6pdx_Ex8_F1 GGAGAAGCTGCCAATGGATA 
G6pdx_Ex9_R1 CCAGGCTTCTTGGTCATCAT 
Gapdh_Mus_Ex2_F2 ACTCCACTCACGGCAAATTC 
Gapdh_Mus_Ex3_R2 GTGGTTCACACCCATCACAA 
Hsa_TKTL1_3'UTR_F5 TTGGCCTCTTTACCCTGTGT 
Hsa_TKTL1_3'UTR_R5 CCTAACAAGCTTTCGCTGCT 
Hsa_TKTL1_5'UTR_F4 GAGCCCTTTTGAGATTGCAG 
Hsa_TKTL1_5'UTR_R4 CCCAGTGCGTTTATGTGATG 
Mus_Tktl1_Ex1_RT_F1 GTTCCATCAAGGCCACAAAT 
Mus_Tktl1_Ex12_RT_F3 ACAGGTGGCCGAATTATCAC 
Mus_Tktl1_Ex13_RT_R3 AGATGCATTTCACAGCCACA 
Mus_Tktl1_Ex3_RT_R1 TAGTCCTTGTCCAGGCCATC 
Mus_Tktl1_Ex5_RT_F2 AGCTCAAGTGAGAGGCAAGC 
Mus_Tktl1_Ex6_RT_R2 TGAGGCGAGTCCTCAATAGG 
TKT_Hsa_Ex2_F CACACCATGCGCTACAAGTC 
TKT_Hsa_Ex4_R GTCGAAGTATTTGCCGGTGT 
Tkt_mus_3'UTR_F1 AGGTCCCACAACTCCTCCTT 
Tkt_mus_3'UTR_R1 GCCCTAAGATCACCCACTGA 
TKTL1 3' 1F TTTGGCCTCTTTACCCTGTG 
TKTL1 3' 1R CAGAAGGCACGTGCTGAATA 
Tktl1 E1F GCTAGTGCCGGAACTTTTTG 
Tktl1 E1R TAGTGCCTCGCTGCCATCTA 
TKTL1_ex11_R GCTTTTGCACTGGAGACGAT 
TKTL1_ex9_F GACCACCCGACCAGAAACTA 
Tktl1_F19a AGCTCAAGTGAGAGGCAAGC 
TKTL1_Hsa_5'SNP_1F GCTAGTGCCGGAACTTTTTG 
TKTL1_Hsa_5'SNP_1R TGGCCATATCTTGCAACACC 
Tktl1_mus_F23 CCACCCCTACTGCACTGATT 
Tktl1_mus_F46 CAACACACATTTGCTTTACT 
Tktl1_mus_R23 ACACCAGAAGAGGGCATCAC 
Tktl1_mus_R46 CACCTTTGTTCCACATTCAGA 
TKTL1_Pro_SNP_F1 GCTAGTGCCGGAACTTTTTG 
TKTL1_Pro_SNP_R1 CAACCCCTTTGGAGTCTGAA 
Tktl1_R19 TGAGGCGAGTCCTCAATAGG 
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Antibody Table 
 
Antibody Name Company Catalog 
AKT Pan Monoclonal Antibody Thermo Fisher MA5-14999 
Phospho-Threonine Antibody (P-Thr-Polyclonal) Cell Signaling Technology 9381 
TKTL1 Polyclonal Antibody Thermo Fisher PA5-28977 
β-Actin Antibody N-21 Santa Cruz sc-130656 
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